Actuate (BIRT) 10-Q 8 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 31, 2013
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'BIRT	'
Entity Registrant Name	'ACTUATE CORP	'
Entity Central Index Key	'0001062478	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	47,637,426

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$40,202	$37,483
Short-term investments	31,746	28,967
Accounts receivable, net of allowances of $548 and $394 at September 30, 2013 and December 31, 2012, respectively	30,403	33,053
Other current assets	10,340	9,098
Total current assets	112,691	108,601
Property and equipment, net	6,559	7,805
Goodwill	51,865	51,821
Purchased intangibles, net	9,222	11,163
Non-current deferred tax assets, net	11,910	12,214
Other assets	763	911
Total current assets	193,010	192,515
Current liabilities:	'	'
Accounts payable	1,775	1,976
Current portion of restructuring liabilities	157	509
Accrued compensation	6,355	6,504
Other accrued liabilities	4,228	5,626
Deferred revenue	41,468	43,438
Total current liabilities	53,983	58,053
Long-term liabilities:	'	'
Notes payable	874	843
Other liabilities	3,186	3,157
Long-term deferred revenue	2,526	2,978
Long-term income taxes payable	2,157	2,127
Total long-term liabilities	8,743	9,105
Stockholders' equity:	'	'
Preferred stock, $0.001 par value, issuable in series; 5,000,000 shares authorized; none issued or outstanding	'	'
Common stock, $0.001 par value, 100,000,000 shares authorized; issued 91,336,812 and 89,179,966 shares, respectively; outstanding 47,943,440 and 48,220,978 shares, respectively	48	48
Additional paid-in capital	253,630	237,731
Treasury stock, at cost; 43,393,372 and 40,958,988 shares, respectively	-189,030	-172,880
Accumulated other comprehensive income	1,832	2,198
Retained earnings	63,804	58,260
Total stockholders' equity	130,284	125,357
Total liabilities and stockholders' equity	$193,010	$192,515

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowances	$548	$394
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	91,336,812	89,179,966
Common stock, shares outstanding	47,943,440	48,220,978
Treasury stock at cost	43,393,372	40,958,988

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:	'	'	'	'
License fees	$14,338	$13,304	$45,973	$42,389
Services	17,953	18,875	56,138	60,854
Total revenues	32,291	32,179	102,111	103,243
Costs and expenses:	'	'	'	'
Cost of license fees	539	482	1,663	1,439
Cost of services	4,196	5,187	13,610	15,267
Sales and marketing	13,862	12,067	41,952	35,811
Research and development	6,422	6,060	19,364	17,668
General and administrative	5,156	5,360	17,204	16,918
Amortization of other purchased intangibles	301	289	865	867
Restructuring charges	246	21	837	54
Total costs and expenses	30,722	29,466	95,495	88,024
Income from operations	1,569	2,713	6,616	15,219
Interest income and other income/(expense), net	-159	174	158	763
Interest expense	-37	-55	-157	-255
Income before income taxes	1,373	2,832	6,617	15,727
Provision for income taxes	138	2,725	1,050	6,182
Net income	$1,235	$107	$5,567	$9,545
Basic net income per share	$0.03	$0	$0.12	$0.19
Shares used in basic per share calculation	48,175	49,207	48,046	49,156
Diluted net income per share	$0.02	$0	$0.11	$0.18
Shares used in diluted per share calculation	51,428	52,794	50,851	52,794

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net income	$1,235	$107	$5,567	$9,545
Other comprehensive income, before tax:	'	'	'	'
Foreign currency translation	1,243	257	-342	161
Net unrealized gain/(loss) on securities	55	60	-24	74
Total comprehensive income	$2,533	$424	$5,201	$9,780

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating activities	'	'
Net income	$5,567	$9,545
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Share-based compensation expense	5,792	5,454
Excess tax benefit from exercise of stock options	-1,118	-2,440
Amortization of other purchased intangibles	1,908	1,687
Amortization of debt issuance cost	44	51
Bad debt expense	-119	-13
Write-off of unamortized debt issuance costs	188	'
Depreciation	1,609	1,587
Change in valuation allowance on deferred tax assets	-28	1,767
Impairments and write-offs	155	89
Gain on liquidation of subsidiary	-416	'
Accretion/amortization on short-term debt securities	-208	189
Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:	'	'
Accounts receivable	2,769	6,717
Other current assets	610	-2,635
Accounts payable	-212	-241
Accrued compensation	-149	-637
Other accrued liabilities	-1,398	-521
Deferred tax assets, net of liabilities	418	170
Income taxes receivable/payable, net	-650	-872
Other deferred liabilities	-47	3,138
Restructuring liabilities	-275	-69
Deferred revenue	-2,422	-6,384
Net cash provided by operating activities	12,018	16,582
Investing activities	'	'
Purchases of property and equipment	-508	-5,038
Proceeds from sale and maturity of investments	31,877	22,694
Purchases of short-term investments	-34,471	-29,286
Proceeds from security deposits and other	10	-55
Net cash used in investing activities	-3,092	-11,685
Financing activities	'	'
Credit facility related payments	-93	-34
Excess tax benefit from exercise of stock options	1,118	2,440
Proceeds from issuance of common stock	8,879	9,223
Stock repurchases	-16,153	-15,993
Tax related to net share settlements of restricted stock awards and units	-50	'
Net cash used in financing activities	-6,299	-4,364
Effect of exchange rates on cash and cash equivalents	92	161
Net increase in cash and cash equivalents	2,719	694
Cash and cash equivalents at the beginning of the period	37,483	38,759
Cash and cash equivalents at the end of the period	40,202	39,453
Supplemental cash flow disclosures:	'	'
Cash paid for interest	76	212
Cash paid for income taxes	1,068	3,448
Non-cash Investing activities:	'	'
Leasehold incentives subsidized by the landlord	'	$2,613

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Summary of Significant Accounting Policies	'
	1. Summary of Significant Accounting Policies
	The Company
	Actuate Software Corporation was incorporated in November 1993 in the State of California and reincorporated in the State of Delaware in July 1998 as Actuate Corporation (“We”, “Actuate” or the “Company”). Actuate provides software to more than 3 million developers who use BIRT, the open source Eclipse-based interactive development environment (IDE) founded and co-led by Actuate. Organizations use Actuate products to create customer-facing, Big Data analytics and customer communications management (CCM) applications that provide end users with content they can easily access, understand and analyze. Developers use BIRT and BIRT iHub, Actuate’s commercial deployment platform for BIRT-based applications, to develop and deploy scalable solutions that save time and improve brand experience by delivering personalized analytics and insights to over 200 million of their customers, partners and employees. BIRT iHub further ensures organizations can gain effective insights from Big Data and take advantage of mobile touch devices. Actuate’s BIRT Analytics™ delivers self-service predictive analytics to enhance customer engagement using Big Data. Actuate for CCM empowers ECM architects to easily transform, process, personalize and archive high volume content. Actuate customers develop solutions that maximize revenue, cut costs, communicate more effectively with customers, streamline operations and create competitive advantage. Actuate’s goal is to ensure that end users can seamlessly incorporate information and business analysis into their day-to-day activities and decision-making, enabling organizations to explore new avenues for improving the bottom line.
	Actuate’s principal executive offices are located at the BayCenter Campus at 951 Mariners Island Boulevard, in San Mateo, California. Actuate’s telephone number is 650-645-3000. Actuate maintains Web sites at www.actuate.com, www.birt-exchange.org, www.birt-exchange.com, www.birtperformanceanalytics.com, www.xenos.com, www.birtondemand.com and www.quiterian.com. The information posted on our Web sites is not incorporated into this Form 10-Q.
	Basis of Presentation
	The Company has prepared the accompanying unaudited Condensed Consolidated Financial Statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, the Company has condensed or omitted certain information and footnote disclosures it normally includes in its annual Consolidated Financial Statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). In management’s opinion, the Company has made all adjustments necessary to fairly present its financial position, results of operations and cash flows. The Company’s interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the Consolidated Financial Statements and notes thereto in Actuate’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the SEC on March 8, 2013.
	To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited Condensed Consolidated Financial Statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on the Company’s operating results and financial position.
	The Condensed Consolidated Financial Statements include the accounts of Actuate and its wholly-owned subsidiaries. Actuate has offices throughout North America, Europe and Asia including offices in the United States, Canada, Switzerland, United Kingdom, Germany, France, Spain, Singapore, Australia, Japan and China. All intercompany balances and transactions have been eliminated.
	Revenue Recognition
	Actuate generates revenues from the sales of software licenses and related services. The Company receives software license revenues from licensing its products directly to end-users and indirectly through resellers, system integrators and original equipment manufacturers (OEMs). The Company receives service revenues from maintenance contracts, consulting services and training that Actuate performs for customers.
	For sales to end-user customers, Actuate recognizes license revenues when a license agreement has been signed by both parties or a definitive agreement has been received from the customer, the product has been physically shipped or electronically made available, there are no unusual uncertainties surrounding the product acceptance, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence (VSOE) of fair value exists to allocate the fee to the undelivered elements of the arrangement. Vendor-specific objective evidence of fair value of sales to end users is based on the price charged when an element is sold separately.
	Actuate has not established vendor-specific objective evidence of fair value for its licenses. Therefore, the Company recognizes revenues from software arrangements with multiple elements involving software licenses under the residual method, which means the fair value of the undelivered elements is deferred while the remaining value of the arrangement is allocated to the delivered elements. If we are unable to determine the fair value of the undelivered elements, it is not possible to allocate revenues separately to the undelivered elements in the arrangement and consequently, the entire amount of the arrangement fee is recognized ratably over the performance period of that undelivered element, assuming all other revenue recognition criteria are satisfied. If the license agreement contains payment terms that would indicate that the fee is not fixed or determinable, revenues are recognized as the payments become due and payable, assuming that all other revenue recognition criteria are met.
	Actuate enters into reseller and distributor arrangements that typically give such distributors and resellers the right to distribute its products to end-users headquartered in specified territories. Actuate recognizes license revenues from arrangements with U.S. resellers and distributors when there is persuasive evidence of an arrangement with the reseller or distributor, the product has been shipped, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence of fair value exists to allocate the fee to the undelivered elements of the arrangement. Actuate recognizes license revenues from arrangements with international resellers and distributors upon receipt of evidence of sell-through and when all other revenue recognition criteria have been met. If it is not practical to obtain evidence of sell-through, the Company defers revenues until the end-user has been identified and cash has been received. In some instances there is a timing difference between when a reseller completes its sale to the end-user and the period in which Actuate receives the documentation required for revenue recognition. Because Actuate delays revenue recognition until the reporting period in which the required documentation is obtained, it may recognize revenue in a period subsequent to the period in which the reseller completes the sale to its end-user.
	Actuate also enters into OEM arrangements that provide for license fees based on the bundling or embedding of its products with the OEM’s products. These arrangements generally provide for fixed, irrevocable royalty payments. Actuate recognizes license fee revenues from U.S. and international OEM arrangements when a license agreement has been executed by both parties, the product has been shipped, there are no unusual uncertainties surrounding the product acceptance, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence of fair value exists to allocate the fee to the undelivered elements of the arrangement.
	Actuate also has two software-as-a-service (SaaS) offerings called OnPerformance and BIRT iHub On Demand. Actuate recognizes revenue on these licenses ratably over the term of the underlying arrangement.
	The Company establishes vendor specific objective evidence of fair value for maintenance and support using a “bell-shaped curve” approach for certain types of license transactions, and uses a “stated maintenance renewal” approach for other categories of license transactions. When applying the “bell-shaped curve” approach the Company analyzes all maintenance renewal transactions over the past twelve months for that category of license and plots those data points on a bell-shaped curve to ensure that a high percentage of the data points are within an acceptable margin of the established VSOE rate. This analysis is performed quarterly.
	When applying the “state renewal rate” approach, the Company ensures that the individual license transaction includes a clear and substantive renewal rate explicitly stated in the documentation for the transaction. Furthermore, the Company ensures that it has a practice of consistently renewing those transactions at the contractual rate. This is done by reviewing maintenance renewals on these contracts and making sure that a very high percentage are renewed at the renewal rates stipulated in the contract.
	The Company assesses the collectability of fees from end-users based on payment history and current credit profile. When a customer is not deemed credit-worthy, revenues are deferred and recognized upon cash receipt.
	Actuate recognizes maintenance revenues, which consist of fees for ongoing support and unspecified product updates, ratably over the term of the contract, typically one year. Consulting revenues are primarily related to standard implementation and configuration. Training revenues are generated from classes offered at the Company’s offices and customer locations. Revenues from consulting and training services are typically recognized as the services are performed. When a contract includes both license and service elements, the license fee is typically recognized on delivery of the software, assuming all other revenue recognition criteria are met, provided services do not include significant customization or modification of the product and are not otherwise essential to the functionality of the software.
	Share-Based Compensation
	The Company has various types of share-based compensation plans. These plans are administered by the compensation committee of the Board of Directors, which selects persons to receive awards and determines the number of shares subject to each award and the terms, conditions, performance measures and other provisions of the award. Readers should refer to Note 9 of the Company’s Consolidated Financial Statements in the Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for additional information related to these share-based compensation plans. Share-based compensation expense and the related income tax benefit reflected in the Condensed Consolidated Statements of Income in connection with stock options, restricted stock units and the Employee Stock Purchase Plan (“ESPP”) for three and nine months ended September 30, 2013 and 2012 were as follows (in thousands):
		Three Months Ended						Nine Months Ended
		September 30,			September 30,			September 30,		September 30,
		2013			2012			2013		2012
	Stock options	$	737		$	1,490		$	2,922	$	3994
	Restricted stock units		453			341			1,287		865
	Performance stock units (“MSUs”)		276			229			776		353
	ESPP		235			150			807		392
	Total share-based compensation	$	1,701		$	2,210		$	5,792	$	5,604
	Income tax benefit	$	524		$	711		$	1,738	$	1,805
	Included in the total share-based compensation for the three and nine months ending September 30, 2012 are approximately $16,000 of credits to stock based compensation and approximately $150,000 of stock based compensation classified as liability based awards related to February 2011 options granted to a senior executive who had passed away in December 2010. These options were either fully exercised or had expired as of December 31, 2012. Accordingly, the Company incurred no similar compensation expense in the first nine months of 2013 and has no liabilities at September 30, 2013 related to these liability-based awards.
	In May 2012, market-performance based restricted stock units (“MSUs”) were granted to the Chief Executive Officer and Chief Financial Officer of the Company. Each MSU represents the right to one share of Actuate’s common stock. The actual number of MSUs which will be eligible to vest will be based on the performance of Actuate’s stock price relative to the performance of the S&P Small Cap 600 Index over a two-year vesting period, up to 200% of the MSUs initially granted. After the initial performance period, 50% of the earned award vests immediately and the remaining 50% is subject to an additional one year service vesting period. We value the MSUs using the Monte Carlo simulation model and amortize the compensation expense over the three year performance and service period.
	In April 2013, additional MSUs were granted to the Chief Executive Officer and Chief Financial Officer of the Company. The actual number of MSUs which will be eligible to vest will be based on the performance of Actuate’s stock price relative to the performance of the Russell 2000 Index over a two and three year vesting period, up to 200% of the MSUs initially granted. The award is divided into two tranches. The first tranche has a two year performance period and the second a three year performance period. We value the MSUs using the Monte Carlo simulation model and amortize the compensation expense over the two and three year performance periods.
	The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing model. We estimated the expected term of options granted by analyzing actual historical experience of exercises and cancellations under our plan. We also looked at the average length of time in which our current outstanding options are expected to be exercised or cancelled based on past experience and the vesting and contractual term. We estimated the volatility of our common stock by using historical volatility over the calculated expected term. We based the risk-free interest rate that we use in the option valuation model on the published Treasury rate. We do not anticipate paying any cash dividends in the foreseeable future and therefore used an expected dividend yield of zero in the option valuation model. The assumptions used to estimate the fair value of stock options granted and stock purchase rights granted under our Employee Stock Purchase Plan (the “Purchase Plan”) for the nine months ended September 30, 2013 and 2012 are as follows:
		Options			ESPP
		Nine Months Ended			Nine Months Ended
		September 30,		September 30,	September 30,		September 30,
		2013		2012	2013		2012
	Volatility	50.03 – 53.58%		53.67 – 54.17%	28.63 – 41.52%		42.12 – 44.17%
	Expected term (years)	5.61 – 5.67		5.60 – 5.63	1.25		1.25
	Risk free interest rate	0.77 – 1.40%		0.63 – 1.01%	0.08 – 0.35%		0.13 – 0.17%
	Expected dividend yield	0%		0%	0%		0%
	Forfeiture rate	2 – 3%		2 – 4%	N/A		N/A
	Beginning January 2010, restricted stock units (“RSUs”) were granted to senior management as part of the Company’s annual incentive compensation program under the Amended and Restated 1998 Equity Incentive Plan. RSUs are valued based on the closing price of the Company’s common stock on the grant date. In general, restricted stock units vest annually over four years and are subject to the employees’ continuing service to the Company. For each restricted stock unit granted under the 1998 Plan, a share reserve ratio is applied for the purpose of determining the remaining number of shares reserved for future grants under the plan. The share reserve ratio is 1:1 for each restricted stock unit granted, and an equivalent of 1 share will be deducted from the share reserve for each restricted stock unit issued. Likewise, each forfeited restricted stock unit increases the number of shares available for issuance by the applicable rate at the time of forfeiture. As of September 30, 2013, a total of 1,446,250 RSUs were issued and granted to the Company’s senior management, employees and non-employee Board of Directors.
	Net Income Per Share
	The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period, less weighted average shares subject to repurchase. The Company computes diluted net income per share using the weighted-average number of common shares and dilutive share-based awards during the period determined by using the treasury stock method.
	The table below reconciles the weighted-average common shares used to calculate basic net income per share with the weighted-average common shares used to calculate diluted net income per share (in thousands).
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013		2012
	Weighted-average common shares outstanding		48,175			49,207			48,046		49,156
	Weighted-average dilutive common equivalent shares under the treasury stock method		3,253			3,587			2,805		3,638
	Weighted-average common shares used in computing diluted net income per share		51,428			52,794			50,851		52,794
	Under the treasury stock method, stock options with exercise prices exceeding the average share price of the Company’s common stock during the applicable period are excluded from the diluted earnings per share computation. The weighted-average number of shares excluded from the calculation of diluted net income was 652,677 and 1,880,436 in the three and nine months ended September 30, 2013, respectively. The weighted-average number of restricted stock unit shares excluded from the calculation of diluted net income was 103,175 and 119,091 in the three and nine months ended September 30, 2013, respectively. The weighted-average number of shares excluded from the calculation of diluted net income was 2,222,368 and 2,151,624 in the three and nine months ended September 30, 2012, respectively. The weighted-average number of restricted stock unit shares excluded from the calculation of diluted net income was 216,200 and 113,349 in the three and nine months ended September 30, 2012, respectively.
	The weighted average exercise price of excluded stock options was $6.16 and $6.01 for the three and nine months ended September 30, 2013, respectively. The weighted average exercise price of excluded stock options was $6.41 and $6.34 for the three and nine months ended September 30, 2012, respectively.
	Income Taxes
	We provide for the effect of income taxes in our Condensed Consolidated Financial Statements using the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, net operating loss carryovers, and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. We also apply a two-step approach to determining the financial statement recognition and measurement of uncertain tax positions.
	Income tax expense or benefit is recognized for the amount of taxes payable or refundable for the current year, and for deferred tax assets and liabilities for the tax consequences of events that have been recognized in an entity’s financial statements or tax returns. We must make significant assumptions, judgments and estimates to determine our current provision (benefit) for income taxes, our deferred tax assets and liabilities, and any valuation allowance to be recorded against our deferred tax assets. Our judgments, assumptions and estimates relating to the current provision (benefit) for income taxes include the geographic mix and amount of income (loss), our interpretation of current tax laws, and possible outcomes of current and future audits conducted by foreign and domestic tax authorities. Our judgments also include anticipating the tax positions we will record in the financial statements before actually preparing and filing the tax returns. Our estimates and assumptions may differ from the actual results as reflected in our income tax returns and we record the required adjustments when they are identified or resolved. Changes in our business, tax laws or our interpretation of tax laws, and developments in current and future tax audits, could significantly impact the amounts provided for income taxes in our results of operations, financial position, or cash flows.
	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to tax benefit carry-forwards and to differences between the financial statement amounts of assets and liabilities and their respective tax basis. We regularly review our deferred tax assets for recoverability and establish a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. To make this assessment, we take into account predictions of the amount and category of taxable income from various sources and all available positive and negative evidence about these possible sources of taxable income. The weight given to the potential effect of negative and positive evidence is commensurate with the extent to which the strength of the evidence can be objectively verified. Based on the analysis of positive and negative factors noted above, we have no valuation allowance against U.S. federal deferred tax assets. During the year ended December 31, 2012, management determined that it was “more likely than not” that the Company’s California research and development (R&D) credits would not be realized based on the size of the R&D credit carry-forward and the R&D credits being generated exceeding the R&D credits being utilized. As such, a full valuation allowance was recorded against the Company’s deferred tax asset for California R&D credit carry-forwards. We maintain a full valuation allowance against deferred tax assets in foreign jurisdictions with a history of losses and a partial valuation allowance in foreign jurisdictions where operating results beyond a certain time frame are less reliable. If, in the future, we determine that these deferred tax assets are more likely than not to be realized, a release of all or part, of the related valuation allowance could result in an income tax benefit in the period such determination is made.
	We only recognize an income tax expense or benefit with respect to uncertain tax positions in our financial statements that we judge is more likely than not to be sustained solely on its technical merits in a tax audit, including resolution of any related appeals or litigation processes. To make this judgment, we must interpret complex and sometimes ambiguous tax laws, regulations and administrative practices. If an income tax position meets the more likely than not recognition threshold, then we must measure the amount of the tax benefit to be recognized by determining the largest amount of tax benefit that has a greater than a 50% likelihood of being realized upon effective settlement with a taxing authority that has full knowledge of all of the relevant facts. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible settlement outcomes. To determine if a tax position is effectively settled, we must also estimate the likelihood that a taxing authority would review a tax position after a tax examination has otherwise been completed. We must also determine when it is reasonably possible that the amount of unrecognized tax benefits will significantly increase or decrease in the 12 months after each fiscal year-end. These judgments are difficult because a taxing authority may change its behavior as a result of our disclosures in our financial statements. We must reevaluate our income tax positions on a quarterly basis to consider factors such as changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement would result in recognition of a tax benefit or an additional charge to the tax provision.
	Sales Taxes
	The Company presents its revenues net of sales tax in its Condensed Consolidated Statements of Income.
	Recent Accounting Pronouncements
In 2013, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance clarifying the accounting for the release of cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013 with early adoption permitted. The Company adopted the new guidance effective the first quarter of fiscal 2013. In February 2013, we liquidated one of our subsidiaries in Asia and as a result, recognized favorable cumulative translation adjustments to income in the first quarter of 2013. This adjustment was recorded under the Interest Income and other Income/(Expense), net section of the Company’s Condensed Consolidated Statement of Income.
In 2013, the FASB issued new accounting guidance clarifying the accounting for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. We do not anticipate that this adoption will have a significant impact on our financial position, results of operations, or cash flows.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2013
Acquisitions	'
	2. Acquisitions
	Quiterian S.L.
	In October 2012, the Company acquired Quiterian S.L., a privately held software company that provides visual data mining, social media analytics and predictive analytics for business and other non-technical users. Actuate acquired 100% of the outstanding shares held by the Quiterian shareholders for $5.2 million in cash. This purchase price was entirely paid upon closing, net of a 10% holdback. There are $3 million in potential additional compensation payments which may be required over the three year period after the date of acquisitions which are wholly dependent on the achievement of specific service obligations.
	Under the purchase accounting method, the total purchase price was allocated to Quiterian’s net tangible and intangible assets based upon their estimated fair values as of October 16, 2012. The excess purchase price over the value of the net tangible and identifiable intangible assets was recorded as goodwill.
	Direct transaction costs related to the Quiterian acquisition totaling approximately $354,000 were incurred during the quarter in which the acquisition occurred. These costs include investment banking fees, legal and accounting fees, and other external costs directly related to the acquisition. All costs were directly charged to general and administrative expense on the Condensed Consolidated Statements of Income as incurred.
	The table below represents the allocation of the purchase price to the acquired net assets of Quiterian based on their estimated fair values as of October 16, 2012 and the associated estimated useful life at that date. Also, as with acquisitions that the Company has undertaken in the past, the Company initiated structural changes in its corporate structure in order to incorporate Quiterian. These changes in Company’s organizational structure are ongoing and could affect future estimates and assumptions.
		Amount			Useful life
		(in thousands)			(in years)
	Net tangible assets and liabilities	$	(2,061	)		N/A
	Existing technology		1,682			7
	Customer contracts and relationships		324			7
	Goodwill		5,255			N/A
	Total purchase price allocation	$	5,200
	Net tangible assets and liabilities—Quiterian’ tangible assets and liabilities as of October 16, 2012 were adjusted to their estimated fair value as necessary. Among the net tangible assets assumed were approximately $505,000 in cash and cash equivalents, $519,000 in trade receivables, and $2.2 million in notes payable.
	Identifiable intangible assets—Existing technology acquired primarily consists of Quiterian’ advanced analytics solution which maximizes the value of data while cutting business intelligence costs. The technology was valued using a form of the income approach known as the excess earnings method. In the excess earnings method, value is estimated as the present value of the benefits anticipated from ownership of the subject intangible asset in excess of the returns required on the investment in the contributory assets necessary to realize those benefits. It is based on the theory that all operating assets contribute to the profitability of an enterprise. Therefore, if the estimated earnings associated with a specific asset of a company rely on the use of other company assets, then the estimated earnings of the subject asset must be reduced by appropriate charges for these of these contributory assets. The fair value of the customer contracts and relationships was established using the income approach. We are amortizing the fair value of these intangible assets on a straight-line basis over their respective estimated useful life.
	Goodwill—Goodwill represents the excess of the purchase price over the fair value of the underlying acquired net tangible and intangible assets. The factors that contributed to the recognition of goodwill included securing buyer-specific synergies that increase revenue and profits and are not otherwise available to a marketplace participant. No amount of goodwill is expected to be deductible for tax purposes.

Fair_Value_Measurements_of_Fin

Fair Value Measurements of Financial Assets and Liabilities	9 Months Ended
	Sep. 30, 2013
Fair Value Measurements of Financial Assets and Liabilities	'
	3. Fair Value Measurements of Financial Assets and Liabilities
	The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For certain of our financial instruments, including cash and cash equivalents, short-term investments, accounts receivable, accounts payable, and other current liabilities the carrying amounts approximate their fair value due to the relatively short maturity of these balances.
	The Company has assets that are valued in accordance with the provisions of the authoritative guidance that addresses fair value measurements. This guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows:
		•		Level 1—Valuations based on real-time quotes for transactions in active exchange markets involving identical assets.
		•		Level 2—Valuations based on readily available pricing sources for comparable instruments, identical instruments in less active markets, or models using market observable inputs.
		•		Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
	Assets Measured at Fair Value on a Recurring Basis
	The following table represents information about the Company’s investments measured at fair value (in thousands).
			Fair value of investments as of September 30, 2013
			Total		Quoted Prices		Significant			Significant
					In Active		Other			Unobservable
					Markets for		Observable			Inputs
					Identical		Inputs			(Level 3)
					Assets		(Level 2)
					(Level 1)
	Money market funds (1)		$	6,984	$	6,984	$	—		$	—
	Term deposits (1)			7,034		7,034		—			—
	Commercial paper (2)(3)			6,998		—		6,998			—
	Corporate bonds (2)			25,748		—		25,748			—
			$	46,764	$	14,018	$	32,746		$	—
			Fair value of investments as of December 31, 2012
			Total		Quoted Prices		Significant			Significant
					In Active		Other			Unobservable
					Markets for		Observable			Inputs
					Identical		Inputs			(Level 3)
					Assets		(Level 2)
					(Level 1)
	Money market funds (1)		$	5,595	$	5,595	$	—		$	—
	Term deposits (1)			8,000		8,000		—			—
	Commercial paper (2)			1,599		—		1,599			—
	Corporate bonds (2)			25,368		—		25,368			—
	Federal and municipal obligations (2)			2,000		—		2,000			—
			$	42,562	$	13,595	$	28,967		$	—
	-1	Included in cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheet.
	-2	Included in short-term investments in the Company’s Condensed Consolidated Balances Sheet.
	-3	Of this amount, approximately $1 million was included in cash equivalents at September 30, 2013.
	The Company’s cash, cash equivalents, and short-term investments are as follows (in thousands):
			Cost		Gross		Gross			Estimated
					Unrealized		Unrealized			Fair Value
					Gains		(Losses)
	Balance at September 30, 2013
	Classified as cash and cash equivalents:
	Cash		$	25,184	$	—	$	—		$	25,184
	Term deposits			7,034		—		—			7,034
	Money market funds			6,984		—		—			6,984
	Commercial paper			1,000		—		—			1,000
				40,202		—		—			40,202
	Classified as short-term investments:
	Commercial paper (4)			5,999		—		(1	)		5,998
	Corporate bonds (4)			25,752		—		(4	)		25,748
				31,751		—		(5	)		31,746
	Total		$	71,953	$	—	$	(5	)	$	71,948
	-4	Securities totaling approximately $20.8 million were in an unrealized loss position at September 30, 2013. None of these securities were in a continuous unrealized loss position since December 31, 2012 or were in continuous loss position for greater than 12 months.
			Cost		Gross		Gross			Estimated
					Unrealized		Unrealized			Fair Value
					Gains		(Losses)
	Balance at December 31, 2012
	Classified as cash and cash equivalents:
	Cash		$	23,888	$	—	$	—		$	23,888
	Term deposits			8,000		—		—			8,000
	Money market funds			5,595		—		—			5,595
				37,483		—		—			37,483
	Classified as short-term investments:
Commercial paper (5)			1,599		—		—			1,599
Corporate bonds (5)			25,350		28		(10	)		25,368
Federal and municipal obligations (5)			2,000		—		—			2,000
			28,949		28		(10	)		28,967
Total		$	66,432	$	28	$	(10	)	$	66,450
-5	Securities totaling approximately $11.4 million were in an unrealized loss position at December 31, 2012. None of these securities were in a continuous unrealized loss position for greater than 12 months.
Short-term investments are classified as available-for-sale and are recorded on the Company’s Condensed Consolidated Balance Sheet at fair market value with unrealized gains or losses reported as a separate component of Accumulated Other Comprehensive Income. At September 30, 2013, the Company has classified all of its securities with original maturities beyond 90 days as short-term investments, even though the stated maturity dates may be one year or more beyond the current balance sheet date as these investments remain highly liquid and available for use in current operations.

Restructuring_Charges

Restructuring Charges	9 Months Ended
	Sep. 30, 2013
Restructuring Charges	'
	4. Restructuring Charges
	During the first half of 2013, the Company implemented a plan to restructure its Performance Management Group in North America to align its cost structure with its current business plan. As a result, the Company reduced its workforce by 13 positions and recorded approximately $551,000 of restructuring charges related to employee severance arrangements. Additionally, the Company downsized its facility in Toronto, Canada, and incurred an idle facility charge of approximately $136,000 consisting of net operating lease write offs. The Company also reached a partial settlement related to the restructuring of its French operation in the first half of 2013 and as a result, reversed approximately $178,000 of a previously accrued severance liability in the first half 2013. Additionally, the Company incurred operating expenses associated with its idle Xenos facility in Europe during the first half of 2013.
	During the third quarter of 2013, the Company updated its estimates of sublease income related to its idle facility in Toronto Canada resulting in approximately $145,000 in restructuring expense. Also in Europe, the Company incurred approximately $71,000 in early lease termination costs related to its Xenos idle facility in United Kingdom.
	The Company’s restructuring charges were based on actual and estimated costs incurred including estimates of sublease income on portions of its idle facilities that were periodically updated based on market conditions and in accordance with the Company’s restructuring plans. These estimates were impacted by the rules governing the termination of employees, especially those in foreign countries.
	The following table summarizes the restructuring accrual activity during the nine months ended September 30, 2013 (in thousands):
			Severance			Facility			Total
			& Benefits			Related
	Balance at December 31, 2012		$	424		$	85		$	509
	Restructuring charges (Q1)			62			6			68
	Restructuring charges (Q2)			373			150			523
	Restructuring charges (Q3)			19			227			246
	Cash payments, net of rents collected on sublease			(850	)		(258	)		(1,108	)
	Adjustments (1)			2			(6	)		(4	)
	Balance at September 30, 2013:			30			204			234
	Less: Current portion:			(30	)		(127	)		(157	)
	Long-term balance at September 30, 2013 (2)		$	—		$	77		$	77
	-1	Adjustments mainly reflect the impact of foreign currency translation.
	-2	Included in “Other liabilities—long-term” section of the Condensed Consolidated Balance Sheet.

Segment_and_Geographic_Informa

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2013
Segment and Geographic Information	'
	5. Segment and Geographic Information
	Our primary operations are located in the United States. Revenues from international sources relate to sales, primarily to Europe and Asia. Our revenues by geographic area were as follows (in thousands):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Revenues:
	North America	$	25,679	$	25,064	$	80,231	$	77,211
	Europe, Middle East, and Africa (EMEA)		5,082		4,799		17,675		18,817
	Asia Pacific and others		1,530		2,316		4,205		7,215
		$	32,291	$	32,179	$	102,111	$	103,243
	As of September 30, 2013, we operated solely in one segment, which is the development, marketing and support of our enterprise reporting application platforms. There were no customers that accounted for more than 10% of total revenues in the nine months ended September 30, 2013 or 2012.

Goodwill_and_Other_Purchased_I

Goodwill and Other Purchased Intangible Assets	9 Months Ended
	Sep. 30, 2013
Goodwill and Other Purchased Intangible Assets	'
	6. Goodwill and Other Purchased Intangible Assets
	Goodwill
	The Company performs its annual impairment test of goodwill as of October 1st of each year. Goodwill is not amortized, but is evaluated for impairment on an annual basis or when impairment indicators are present. The potential impairment is identified if the fair value of the reporting unit to which goodwill applies is less than the recorded book value of the related reporting entity, including such goodwill. Where the book value of a reporting entity, including related goodwill, is greater than the reporting entity’s fair value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the impairment test performed on October 1, 2012. As a result, the Company did not record any impairment related to its goodwill for the nine months ended September 30, 2013.
	The Company’s goodwill balance of $51.9 million was unchanged at September 30, 2013 when compared to the balance reported at end of fiscal 2012 except for minor adjustments resulting from foreign currency translation.
	Other purchased intangible assets consist of the following (in thousands):
		September 30, 2013									December 31, 2012
		Gross			Accumulated			Net			Gross		Accumulated			Net
		Carrying			Amortization			Carrying			Carrying		Amortization			Carrying
		Amount						Amount			Amount					Amount
	Customer lists	$	22,350		$	(18,240	)	$	4,110		$	22,360	$	(17,394	)	$	4,966
	Purchased technologies		17,325			(12,194	)		5,131			17,377		(11,202	)		6,175
	Leases		47			(33	)		14			47		(25	)		22
	Foreign currency exchange		(33	)		—			(33	)		—		—			—
		$	39,689		$	(30,467	)	$	9,222		$	39,784	$	(28,621	)	$	11,163
	Amortization expense of purchased technology and other intangible assets was approximately $634,000 and $562,000 for the quarters ended September 30, 2013 and 2012, respectively. Of this total, approximately $333,000 and $273,000 was related to the amortization of purchased technology for the quarters ended September 30, 2013 and 2012, respectively. Amortization expense of purchased intangible assets was approximately $1.9 million and $1.7 million for the nine months ended September 30, 2013 and 2012, respectively. Of this total, approximately $1 million and $820,000 was related to the amortization of purchased technologies for the nine months ended September 30, 2013 and 2012, respectively. Purchased identifiable intangible assets are amortized on a straight-line basis over their useful lives. The estimated useful economic lives of the acquired customer lists and purchased technologies are seven years. The estimated economic useful life of favorable leases is five years. Amortization of purchased technology is included in cost of license fees in the accompanying Condensed Consolidated Statements of Income.
	During the year ended December 31, 2012, the Company recorded additions to its purchased intangible assets of approximately $2 million related to the acquisition of Quiterian. For additional discussion, see Note 2 of this Form 10-Q.
	The expected remaining annual amortization expense is summarized as follows (in thousands):
	Fiscal Year	Purchased
		Technology and
		Intangibles
	2013 (remainder of year)	$	634
	2014		2,536
	2015		2,530
	2016		2,527
	2017 and thereafter		995
		$	9,222

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies	'
	7. Commitments and Contingencies
	General
	The Company is engaged in certain legal actions arising in the ordinary course of business. Although there can be no assurance as to the outcome of such litigation, the Company believes it has adequate legal defenses and it believes that neither the ultimate outcome of any of these actions nor ongoing litigation costs will not have a material effect on the Company’s Consolidated Financial position or results of operations.
	During the second quarter of 2013, following a comparative evaluation of its credit facility, the Company decided to change to another vendor to service its borrowing needs. As a result, the Company terminated its existing credit agreement with Wells Fargo Capital Finance (“WFCF”) and on June 30, 2013 entered into a new revolving credit agreement with U.S. Bank National Association (“US Bank”) through and until June 29, 2017. The Company intends to use the proceeds from the Credit Agreement for working capital, acquisitions, issuance of commercial and standby letters of credit, capital expenditures and other general corporate purposes.
	The new Credit Agreement with US Bank allows for cash borrowings and the issuance of letters of credit under a secured revolving credit facility up to a maximum of $50 million. Interest accrues based on, at the Company’s election, (i) LIBOR plus an applicable spread of between 1.50% and 2.00% based on Company’s consolidated total cash flow leverage ratio or (ii) the greater of: (a) the Federal Funds Effective Rate plus one half of one percent, (b) one month LIBOR plus one percent, and (c) U.S. Bank’s prime rate, in each case plus an applicable spread of between 0.50% and 1.00% based on Company’s consolidated total cash flow leverage ratio. The Company is required to make interest payments on a monthly basis.
	Following the termination of its agreement with WFCF, the Company wrote-off all remaining unamortized costs related to the old credit facility totaling approximately $188,000 in the second quarter of 2013. Costs related to the new credit facility with the US Bank were not significant.
	As of September 30, 2013, there was no balance owed on the credit facility and the balance available under the revolving credit facility was $50 million.
	The following table represents costs related to the Company’s credit facility (in thousands):
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
			2013			2012			2013			2012
	Amortization of debt issuance costs		$	3			17		$	43			51
	Unused line fees			—			38			75			114
			$	3		$	55		$	118		$	165
	The Credit Agreement with US Bank contains covenants, which, among other things, impose certain limitations with respect to lines of business, mergers, investments and acquisitions, additional indebtedness, distributions, guarantees, liens and encumbrances. The Company is also required to maintain the two financial covenants listed below:
		•		Consolidated total cash flow leverage ratio not to exceed 2.50 to 1.00, and
		•		A fixed charge coverage ratio of not less than 1.75 to 1.00.
	The indebtedness under the Credit Agreement is secured by (i) substantially all of the personal property (whether tangible or intangible) of Actuate Corporation and Actuate International Holding Company (as guarantor) as well as the proceeds generated by that property and (ii) by a pledge of all of its stock and a portion of the stock of certain of its subsidiaries.
	Notes payable
	Associated with the acquisition of Quiterian on October 16, 2012, the Company inherited two loan agreements that were previously executed to finance the development of the Quiterian software. The loans were offered by the Spanish government subsidy programs and are restricted for use on development of the software. The loans are scheduled for repayment on a quarterly basis starting June 2014 and ending September 2022. The combined outstanding balances of these loans total approximately $0.9 million and are classified as notes payable on the Company’s Condensed Consolidated Balance Sheet at September 30, 2013.
	Operating Lease Commitments
	On November 28, 2011, the Company entered into a ten year lease agreement with a third party for approximately 58,000 square feet of office space in the BayCenter Campus in San Mateo, California. This lease is operating in nature and commenced on June 1, 2012 and will end on May 31, 2022. In addition, the lease provides for four months of free rent (rent holiday) and approximately $2.6 million in landlord incentives to be applied towards construction of improvements. At September 30, 2013, the deferred rent liability balance related to the new lease totaled approximately $3.4 million and this balance declines through May 2022 when contractual cash payments exceed the straight-line lease expense. Of this total deferred rent liability balance, approximately $261,000 was classified as short term and $3.1 million was classified as long term accrued liabilities on the Company’s Condensed Consolidated Balance Sheet at September 30, 2013. Actuate vacated its previous corporate headquarters located at the Bridgepointe Campus in July 2012 and is now using the BayCenter Campus as its corporate headquarters.
	Upon the execution of the new lease, Actuate delivered to the new landlord two letters of credit totaling $225,300. These letters of credit guarantee Actuate’s contractual obligations related to the BayCenter Campus in San Mateo, California.
	In fiscal 2012, the Company entered into a new lease agreement for one of its sales locations in Europe. Upon the execution of the new lease, Actuate delivered to the new landlord a letter of credit for approximately $88,000 in order to guarantee its contractual obligations related to this lease.
	Actuate leases smaller office facilities in various locations in the United States and abroad. All facilities are leased under operating leases. Total rent expense for the third quarter and first nine months of fiscal 2013 was approximately $1.1 million and $3.3 million, respectively, compared with rent expense of approximately $1.2 million in third quarter and $3.1 million in the first nine months of fiscal 2012. In addition, the Company incurred facility related charges of approximately $128,000 and $441,000 in the third quarter and the first nine months of fiscal 2013, respectively. During the same period last year, the Company incurred approximately $236,000 and $1 million of facilities related charges in the third quarter and the first nine months of fiscal 2012, respectively.
	Stock Option Plans
	An individual who first joins the Board of Directors as a non-employee director is awarded an option to purchase 25,000 shares of the Company’s Common Stock and a restricted stock unit award (“RSU”) covering 12,500 shares of the Company’s Common Stock. These options and RSUs each have a four year vesting period tied to continued Board service. Each option has an exercise price equal to the closing price of the Company’s Common Stock on the day of the grant, and 25% will vest upon the non-employee directors’ continued Board service through the first anniversary of the award date and on an equal, monthly basis over the next 3 years of service thereafter. The first 25% of each restricted stock unit award will vest 13 months following the award date and the remainder will vest in a series of three successive equal annual installments on each of the second, third and fourth anniversaries of the award date, provided that the non-employee director continues in Board service through each such vesting date. Each non-employee director receiving an initial 12,500-share RSU award is given the opportunity to elect to defer the receipt of the shares of Actuate Common Stock that vest and become issuable pursuant to the initial RSU award. If a non-employee director makes a timely deferral election, then the shares of Actuate Common Stock in which he or she vests under the initial RSU award will be issued upon termination of Board service. In the absence of an effective deferral election, any shares of the Company’s Common Stock in which the non-employee director vests under the initial RSU award will be issued as those shares vest.
	Each continuing non-employee director is granted a RSU award covering 16,000 shares of the Company’s Common Stock at each annual stockholders meeting. Each restricted stock unit award granted to a continuing non-employee director will vest upon the non-employee director’s continued Board service through the first anniversary of the award date. Before the start of each calendar year, each of our non-employee directors is given the opportunity to elect to defer the receipt of any or all of the shares of Actuate Common Stock that vest and become issuable pursuant to the restricted stock unit award to be made to such non-employee director at the next annual stockholders meeting. If a non-employee director makes a timely deferral election, then the shares of Actuate Common Stock in which he or she vests under the RSU award will be issued upon his termination of Board service. In the absence of an effective deferral election, any shares of the Company’s Common Stock in which the non-employee director vests under the RSU award will be issued as those shares vest.
	Each restricted stock unit award and each option award granted to a new or continuing non-employee director will vest in full on an accelerated basis upon (i) an approved acquisition of the Company by merger or consolidation, (ii) a sale of all or substantially all of the Company’s assets, (iii) the successful completion of a tender or exchange offer for securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities, or (iv) the death or disability of the optionee while serving as a member of the Board of Directors. Each restricted stock unit that vests will entitle the recipient to one share of the Company’s common stock on the designated issuance date for that share. All grants are made under the 1998 Plan.
	All options are subject to the same vesting schedule (twenty-five percent of the option shares will vest on the one year anniversary of the option grant date and the remaining option shares will vest in thirty-six equal monthly installments over the thirty-six month period measured from the first anniversary of the option grant date, provided the optionee continues to provide services to the Corporation through each applicable vesting date) and all have ten year terms.
	Shares issued as a result of the exercise of options under any of our plans would be fulfilled through shares currently in our existing pools. Total authorized but unissued shares were 22,775,022 as of September 30, 2013.
	Plan Summary		Available for			Options and			Total Authorized But
			Grant			Awards			Unissued
						Outstanding (2)
	Amended and Restated 1998 Equity Incentive Plan			10,392,728			11,093,886			21,486,614
	2001 Supplemental Stock Plan			705,541			35,156			740,697
	1998 Non-Employee Director Option Plan			495,000			105,000			600,000
	Total Stock Plans			11,593,269			11,234,042			22,827,311
	Miscellaneous Stock Grants (1)			(52,289	)		—			(52,289	)
	Total Stock Plans Balance at September 30, 2013			11,540,980			11,234,042			22,775,022
	-1	Board approved 50,000 shares stock grant on February 17, 2011 to the beneficiary of a deceased senior executive in recognition of services performed. Also included are 2,289 shares of stock granted to an employee on April 22, 2013.
	-2	Total balance outstanding at September 30, 2013 includes 9,870,230 of options and 1,363,812 of RSU’s.
	The weighted average grant date fair value of options granted during the quarter ended September 30, 2013 was $3.38 per option. Upon the exercise of options, the Company issues new common stock from its authorized shares. The total intrinsic value of options exercised during the quarter ended September 30, 2013 was $2.4 million.
	All vested stock options are exercisable. The following table summarizes information about stock options outstanding and exercisable as of September 30, 2013:
			Options Outstanding									Options Exercisable
	Range of Exercise Prices		Number of			Weighted-			Weighted-			Number of		Weighted-
			Shares			Average			Average			Shares		Average
						Remaining			Exercise					Exercise
						Contractual			Price					Price
						Life
	$1.86-$3.56			1,219,447			3.81 years		$	3.24			1,219,447	$	3.24
	$3.59-$4.44			1,209,258			2.05 years		$	3.83			1,195,021	$	3.83
	$4.45-$4.80			937,829			6.17 years		$	4.78			841,479	$	4.78
	$4.84-$5.31			1,227,070			4.20 years		$	5.15			1,122,672	$	5.14
	$5.32-$5.48			1,084,705			7.30 years		$	5.48			701,714	$	5.48
	$5.49-$6.00			1,122,529			8.98 years		$	5.57			63,622	$	5.68
	$6.02-$6.29			1,423,253			5.21 years		$	6.13			1,171,473	$	6.12
	$6.30-$8.39			1,646,139			7.80 years		$	6.47			719,100	$	6.52
	$1.86-$8.39			9,870,230			5.71 years		$	5.16			7,034,528	$	4.89
			September 30,			September 30,
			2013			2012
	Options Outstanding—Vested and Expected to Vest (net of expected forfeitures)
	Vested and expected to vest			9,767,803			11,919,426
Aggregate intrinsic value (in thousands)		$	21,474		$	27,111
Weighted average exercise price per share		$	5.15		$	4.76
Weighted average remaining contractual term (in years)			5.67			5.55
Options Exercisable
Options currently exercisable			7,034,528			8,439,892
Aggregate intrinsic value of currently exercisable options (in thousands)		$	17,346		$	22,674
Weighted average exercise price per share		$	4.89		$	4.35
Weighted average remaining contractual term (in years)			4.59			4.38
As of September 30, 2013, the number of shares reserved for future grants under all option plans was 11,540,980. The number of shares available for future purchase under the Purchase Plan was 2,800,301.
Summary of Restricted Stock Units
Restricted stock unit activity for the nine months ended September 30, 2013 and 2012:
		September 30,			September 30,
		2013			2012
Beginning outstanding balance			577,374			384,687
Awarded			447,500			205,000
Released			(21,062	)		(12,313	)
Ending outstanding balance			1,003,812			577,374
The weighted average grant date fair value of restricted stock units granted during the nine months ended September 30, 2013 and 2012 were $5.73 and $6.40 per unit, respectively.
		Number of			Weighted Average			Aggregate
		Units			Remaining			Intrinsic Value
					Contractual Life			(thousands) (3)
					(years)
Restricted stock units outstanding			1,003,812			1.4		$	7,378
Restricted stock units vested and expected to vest (1)			975,043			1.37		$	7,167
Restricted stock units vested and deferred shares (2)			308,375			—		$	2,267
-1	Net of expected forfeitures
-2	Not outstanding, therefore no remaining contractual life.
-3	Intrinsic value is calculated based on market value of the Company’s stock price at the date of reporting.
Summary of Market-Performance Based Restricted Stock Units (“MSUs”)
MSU activity for the nine months ended September 30, 2013 and 2012:
		September 30,			September 30,
		2013			2012
Beginning outstanding balance			235,000			—
Awarded			125,000			235,000
Ending outstanding balance			360,000			235,000
The weighted average grant date fair value of MSUs granted during the nine months ended September 30, 2013 and 2012 were $5.60 and $8.01 per unit, respectively.
		Number of			Weighted Average			Aggregate
		Units			Remaining			Intrinsic Value
					Contractual Life			(thousands) (2)
					(years)
MSUs outstanding			360,000			1.1		$	2,646
MSUs vested and expected to vest (1)			348,238			1.08		$	2,560
-1	Net of expected forfeitures.
-2	Intrinsic value is calculated based on market value of the Company’s stock price at the date of reporting.

Deferred_Revenue

Deferred Revenue	9 Months Ended
	Sep. 30, 2013
Deferred Revenue	'
	8. Deferred Revenue
	Deferred revenue consists of the following (in thousands):
		September 30,			December 31,
		2013			2012
	Maintenance and support	$	40,903		$	41,007
	Other		3,091			5,409
		$	43,994		$	46,416
	Less: current portion		(41,468	)		(43,438	)
	Long-term deferred revenue	$	2,526		$	2,978
	Maintenance and support consists of first year maintenance and support services associated with the initial purchase of Actuate’s software, and the renewal of annual maintenance and support services from customers who purchased Actuate’s software in prior periods. The maintenance and support period is generally 12 months and revenues are typically recognized on a straight-line basis over the term of the maintenance and support period.
	Other deferred revenue consists of deferred license, training and consulting fees generated from arrangements, which did not meet some or all of the revenue recognition criteria of FASB’s Accounting Standards Codification 985—Software, and are, therefore, deferred until all revenue recognition criteria have been met.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events	'
	9. Subsequent Events
	On July 29, 2013, the Board of Directors approved a share repurchase program totaling $40 million over a twelve month period. The timing and amount of any shares repurchased will be determined based on the Company’s evaluation of market conditions and other factors and the program may be discontinued or suspended at any time. Repurchases will be made in compliance with all Securities Exchange Commission (SEC) rules and other legal requirements and will be made in part under a Rule 10b5-1 plan, a rule established by the SEC which permits stock repurchases when the Company might otherwise be precluded from doing so. Subsequent to September 30, 2013, through November 6, 2013, the Company has repurchased 547,899 shares totaling approximately $4.2 million in the open market under this stock repurchase plan.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Basis of Presentation	'
	Basis of Presentation
	The Company has prepared the accompanying unaudited Condensed Consolidated Financial Statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, the Company has condensed or omitted certain information and footnote disclosures it normally includes in its annual Consolidated Financial Statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). In management’s opinion, the Company has made all adjustments necessary to fairly present its financial position, results of operations and cash flows. The Company’s interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the Consolidated Financial Statements and notes thereto in Actuate’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the SEC on March 8, 2013.
	To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited Condensed Consolidated Financial Statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on the Company’s operating results and financial position.
	The Condensed Consolidated Financial Statements include the accounts of Actuate and its wholly-owned subsidiaries. Actuate has offices throughout North America, Europe and Asia including offices in the United States, Canada, Switzerland, United Kingdom, Germany, France, Spain, Singapore, Australia, Japan and China. All intercompany balances and transactions have been eliminated.
Revenue Recognition	'
	Revenue Recognition
	Actuate generates revenues from the sales of software licenses and related services. The Company receives software license revenues from licensing its products directly to end-users and indirectly through resellers, system integrators and original equipment manufacturers (OEMs). The Company receives service revenues from maintenance contracts, consulting services and training that Actuate performs for customers.
	For sales to end-user customers, Actuate recognizes license revenues when a license agreement has been signed by both parties or a definitive agreement has been received from the customer, the product has been physically shipped or electronically made available, there are no unusual uncertainties surrounding the product acceptance, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence (VSOE) of fair value exists to allocate the fee to the undelivered elements of the arrangement. Vendor-specific objective evidence of fair value of sales to end users is based on the price charged when an element is sold separately.
	Actuate has not established vendor-specific objective evidence of fair value for its licenses. Therefore, the Company recognizes revenues from software arrangements with multiple elements involving software licenses under the residual method, which means the fair value of the undelivered elements is deferred while the remaining value of the arrangement is allocated to the delivered elements. If we are unable to determine the fair value of the undelivered elements, it is not possible to allocate revenues separately to the undelivered elements in the arrangement and consequently, the entire amount of the arrangement fee is recognized ratably over the performance period of that undelivered element, assuming all other revenue recognition criteria are satisfied. If the license agreement contains payment terms that would indicate that the fee is not fixed or determinable, revenues are recognized as the payments become due and payable, assuming that all other revenue recognition criteria are met.
	Actuate enters into reseller and distributor arrangements that typically give such distributors and resellers the right to distribute its products to end-users headquartered in specified territories. Actuate recognizes license revenues from arrangements with U.S. resellers and distributors when there is persuasive evidence of an arrangement with the reseller or distributor, the product has been shipped, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence of fair value exists to allocate the fee to the undelivered elements of the arrangement. Actuate recognizes license revenues from arrangements with international resellers and distributors upon receipt of evidence of sell-through and when all other revenue recognition criteria have been met. If it is not practical to obtain evidence of sell-through, the Company defers revenues until the end-user has been identified and cash has been received. In some instances there is a timing difference between when a reseller completes its sale to the end-user and the period in which Actuate receives the documentation required for revenue recognition. Because Actuate delays revenue recognition until the reporting period in which the required documentation is obtained, it may recognize revenue in a period subsequent to the period in which the reseller completes the sale to its end-user.
	Actuate also enters into OEM arrangements that provide for license fees based on the bundling or embedding of its products with the OEM’s products. These arrangements generally provide for fixed, irrevocable royalty payments. Actuate recognizes license fee revenues from U.S. and international OEM arrangements when a license agreement has been executed by both parties, the product has been shipped, there are no unusual uncertainties surrounding the product acceptance, the fees are fixed or determinable, collectability is probable and vendor-specific objective evidence of fair value exists to allocate the fee to the undelivered elements of the arrangement.
	Actuate also has two software-as-a-service (SaaS) offerings called OnPerformance and BIRT iHub On Demand. Actuate recognizes revenue on these licenses ratably over the term of the underlying arrangement.
	The Company establishes vendor specific objective evidence of fair value for maintenance and support using a “bell-shaped curve” approach for certain types of license transactions, and uses a “stated maintenance renewal” approach for other categories of license transactions. When applying the “bell-shaped curve” approach the Company analyzes all maintenance renewal transactions over the past twelve months for that category of license and plots those data points on a bell-shaped curve to ensure that a high percentage of the data points are within an acceptable margin of the established VSOE rate. This analysis is performed quarterly.
	When applying the “state renewal rate” approach, the Company ensures that the individual license transaction includes a clear and substantive renewal rate explicitly stated in the documentation for the transaction. Furthermore, the Company ensures that it has a practice of consistently renewing those transactions at the contractual rate. This is done by reviewing maintenance renewals on these contracts and making sure that a very high percentage are renewed at the renewal rates stipulated in the contract.
	The Company assesses the collectability of fees from end-users based on payment history and current credit profile. When a customer is not deemed credit-worthy, revenues are deferred and recognized upon cash receipt.
	Actuate recognizes maintenance revenues, which consist of fees for ongoing support and unspecified product updates, ratably over the term of the contract, typically one year. Consulting revenues are primarily related to standard implementation and configuration. Training revenues are generated from classes offered at the Company’s offices and customer locations. Revenues from consulting and training services are typically recognized as the services are performed. When a contract includes both license and service elements, the license fee is typically recognized on delivery of the software, assuming all other revenue recognition criteria are met, provided services do not include significant customization or modification of the product and are not otherwise essential to the functionality of the software.
Share-Based Compensation	'
	Share-Based Compensation
	The Company has various types of share-based compensation plans. These plans are administered by the compensation committee of the Board of Directors, which selects persons to receive awards and determines the number of shares subject to each award and the terms, conditions, performance measures and other provisions of the award. Readers should refer to Note 9 of the Company’s Consolidated Financial Statements in the Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for additional information related to these share-based compensation plans. Share-based compensation expense and the related income tax benefit reflected in the Condensed Consolidated Statements of Income in connection with stock options, restricted stock units and the Employee Stock Purchase Plan (“ESPP”) for three and nine months ended September 30, 2013 and 2012 were as follows (in thousands):
		Three Months Ended						Nine Months Ended
		September 30,			September 30,			September 30,		September 30,
		2013			2012			2013		2012
	Stock options	$	737		$	1,490		$	2,922	$	3994
	Restricted stock units		453			341			1,287		865
	Performance stock units (“MSUs”)		276			229			776		353
	ESPP		235			150			807		392
	Total share-based compensation	$	1,701		$	2,210		$	5,792	$	5,604
	Income tax benefit	$	524		$	711		$	1,738	$	1,805
	Included in the total share-based compensation for the three and nine months ending September 30, 2012 are approximately $16,000 of credits to stock based compensation and approximately $150,000 of stock based compensation classified as liability based awards related to February 2011 options granted to a senior executive who had passed away in December 2010. These options were either fully exercised or had expired as of December 31, 2012. Accordingly, the Company incurred no similar compensation expense in the first nine months of 2013 and has no liabilities at September 30, 2013 related to these liability-based awards.
	In May 2012, market-performance based restricted stock units (“MSUs”) were granted to the Chief Executive Officer and Chief Financial Officer of the Company. Each MSU represents the right to one share of Actuate’s common stock. The actual number of MSUs which will be eligible to vest will be based on the performance of Actuate’s stock price relative to the performance of the S&P Small Cap 600 Index over a two-year vesting period, up to 200% of the MSUs initially granted. After the initial performance period, 50% of the earned award vests immediately and the remaining 50% is subject to an additional one year service vesting period. We value the MSUs using the Monte Carlo simulation model and amortize the compensation expense over the three year performance and service period.
	In April 2013, additional MSUs were granted to the Chief Executive Officer and Chief Financial Officer of the Company. The actual number of MSUs which will be eligible to vest will be based on the performance of Actuate’s stock price relative to the performance of the Russell 2000 Index over a two and three year vesting period, up to 200% of the MSUs initially granted. The award is divided into two tranches. The first tranche has a two year performance period and the second a three year performance period. We value the MSUs using the Monte Carlo simulation model and amortize the compensation expense over the two and three year performance periods.
	The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing model. We estimated the expected term of options granted by analyzing actual historical experience of exercises and cancellations under our plan. We also looked at the average length of time in which our current outstanding options are expected to be exercised or cancelled based on past experience and the vesting and contractual term. We estimated the volatility of our common stock by using historical volatility over the calculated expected term. We based the risk-free interest rate that we use in the option valuation model on the published Treasury rate. We do not anticipate paying any cash dividends in the foreseeable future and therefore used an expected dividend yield of zero in the option valuation model. The assumptions used to estimate the fair value of stock options granted and stock purchase rights granted under our Employee Stock Purchase Plan (the “Purchase Plan”) for the nine months ended September 30, 2013 and 2012 are as follows:
		Options			ESPP
		Nine Months Ended			Nine Months Ended
		September 30,		September 30,	September 30,		September 30,
		2013		2012	2013		2012
	Volatility	50.03 – 53.58%		53.67 – 54.17%	28.63 – 41.52%		42.12 – 44.17%
	Expected term (years)	5.61 – 5.67		5.60 – 5.63	1.25		1.25
	Risk free interest rate	0.77 – 1.40%		0.63 – 1.01%	0.08 – 0.35%		0.13 – 0.17%
	Expected dividend yield	0%		0%	0%		0%
	Forfeiture rate	2 – 3%		2 – 4%	N/A		N/A
	Beginning January 2010, restricted stock units (“RSUs”) were granted to senior management as part of the Company’s annual incentive compensation program under the Amended and Restated 1998 Equity Incentive Plan. RSUs are valued based on the closing price of the Company’s common stock on the grant date. In general, restricted stock units vest annually over four years and are subject to the employees’ continuing service to the Company. For each restricted stock unit granted under the 1998 Plan, a share reserve ratio is applied for the purpose of determining the remaining number of shares reserved for future grants under the plan. The share reserve ratio is 1:1 for each restricted stock unit granted, and an equivalent of 1 share will be deducted from the share reserve for each restricted stock unit issued. Likewise, each forfeited restricted stock unit increases the number of shares available for issuance by the applicable rate at the time of forfeiture. As of September 30, 2013, a total of 1,446,250 RSUs were issued and granted to the Company’s senior management, employees and non-employee Board of Directors.
Net Income Per Share	'
	Net Income Per Share
	The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period, less weighted average shares subject to repurchase. The Company computes diluted net income per share using the weighted-average number of common shares and dilutive share-based awards during the period determined by using the treasury stock method.
	The table below reconciles the weighted-average common shares used to calculate basic net income per share with the weighted-average common shares used to calculate diluted net income per share (in thousands).
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013		2012
	Weighted-average common shares outstanding		48,175			49,207			48,046		49,156
	Weighted-average dilutive common equivalent shares under the treasury stock method		3,253			3,587			2,805		3,638
	Weighted-average common shares used in computing diluted net income per share		51,428			52,794			50,851		52,794
	Under the treasury stock method, stock options with exercise prices exceeding the average share price of the Company’s common stock during the applicable period are excluded from the diluted earnings per share computation. The weighted-average number of shares excluded from the calculation of diluted net income was 652,677 and 1,880,436 in the three and nine months ended September 30, 2013, respectively. The weighted-average number of restricted stock unit shares excluded from the calculation of diluted net income was 103,175 and 119,091 in the three and nine months ended September 30, 2013, respectively. The weighted-average number of shares excluded from the calculation of diluted net income was 2,222,368 and 2,151,624 in the three and nine months ended September 30, 2012, respectively. The weighted-average number of restricted stock unit shares excluded from the calculation of diluted net income was 216,200 and 113,349 in the three and nine months ended September 30, 2012, respectively.
	The weighted average exercise price of excluded stock options was $6.16 and $6.01 for the three and nine months ended September 30, 2013, respectively. The weighted average exercise price of excluded stock options was $6.41 and $6.34 for the three and nine months ended September 30, 2012, respectively.
Income Taxes	'
	Income Taxes
	We provide for the effect of income taxes in our Condensed Consolidated Financial Statements using the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, net operating loss carryovers, and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. We also apply a two-step approach to determining the financial statement recognition and measurement of uncertain tax positions.
	Income tax expense or benefit is recognized for the amount of taxes payable or refundable for the current year, and for deferred tax assets and liabilities for the tax consequences of events that have been recognized in an entity’s financial statements or tax returns. We must make significant assumptions, judgments and estimates to determine our current provision (benefit) for income taxes, our deferred tax assets and liabilities, and any valuation allowance to be recorded against our deferred tax assets. Our judgments, assumptions and estimates relating to the current provision (benefit) for income taxes include the geographic mix and amount of income (loss), our interpretation of current tax laws, and possible outcomes of current and future audits conducted by foreign and domestic tax authorities. Our judgments also include anticipating the tax positions we will record in the financial statements before actually preparing and filing the tax returns. Our estimates and assumptions may differ from the actual results as reflected in our income tax returns and we record the required adjustments when they are identified or resolved. Changes in our business, tax laws or our interpretation of tax laws, and developments in current and future tax audits, could significantly impact the amounts provided for income taxes in our results of operations, financial position, or cash flows.
	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to tax benefit carry-forwards and to differences between the financial statement amounts of assets and liabilities and their respective tax basis. We regularly review our deferred tax assets for recoverability and establish a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. To make this assessment, we take into account predictions of the amount and category of taxable income from various sources and all available positive and negative evidence about these possible sources of taxable income. The weight given to the potential effect of negative and positive evidence is commensurate with the extent to which the strength of the evidence can be objectively verified. Based on the analysis of positive and negative factors noted above, we have no valuation allowance against U.S. federal deferred tax assets. During the year ended December 31, 2012, management determined that it was “more likely than not” that the Company’s California research and development (R&D) credits would not be realized based on the size of the R&D credit carry-forward and the R&D credits being generated exceeding the R&D credits being utilized. As such, a full valuation allowance was recorded against the Company’s deferred tax asset for California R&D credit carry-forwards. We maintain a full valuation allowance against deferred tax assets in foreign jurisdictions with a history of losses and a partial valuation allowance in foreign jurisdictions where operating results beyond a certain time frame are less reliable. If, in the future, we determine that these deferred tax assets are more likely than not to be realized, a release of all or part, of the related valuation allowance could result in an income tax benefit in the period such determination is made.
	We only recognize an income tax expense or benefit with respect to uncertain tax positions in our financial statements that we judge is more likely than not to be sustained solely on its technical merits in a tax audit, including resolution of any related appeals or litigation processes. To make this judgment, we must interpret complex and sometimes ambiguous tax laws, regulations and administrative practices. If an income tax position meets the more likely than not recognition threshold, then we must measure the amount of the tax benefit to be recognized by determining the largest amount of tax benefit that has a greater than a 50% likelihood of being realized upon effective settlement with a taxing authority that has full knowledge of all of the relevant facts. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible settlement outcomes. To determine if a tax position is effectively settled, we must also estimate the likelihood that a taxing authority would review a tax position after a tax examination has otherwise been completed. We must also determine when it is reasonably possible that the amount of unrecognized tax benefits will significantly increase or decrease in the 12 months after each fiscal year-end. These judgments are difficult because a taxing authority may change its behavior as a result of our disclosures in our financial statements. We must reevaluate our income tax positions on a quarterly basis to consider factors such as changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement would result in recognition of a tax benefit or an additional charge to the tax provision.
Sales Taxes	'
	Sales Taxes
	The Company presents its revenues net of sales tax in its Condensed Consolidated Statements of Income.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In 2013, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance clarifying the accounting for the release of cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013 with early adoption permitted. The Company adopted the new guidance effective the first quarter of fiscal 2013. In February 2013, we liquidated one of our subsidiaries in Asia and as a result, recognized favorable cumulative translation adjustments to income in the first quarter of 2013. This adjustment was recorded under the Interest Income and other Income/(Expense), net section of the Company’s Condensed Consolidated Statement of Income.
	In 2013, the FASB issued new accounting guidance clarifying the accounting for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. We do not anticipate that this adoption will have a significant impact on our financial position, results of operations, or cash flows.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2013
Share-Based Compensation Expense and Related Income Tax Benefit	'
	Share-based compensation expense and the related income tax benefit reflected in the Condensed Consolidated Statements of Income in connection with stock options, restricted stock units and the Employee Stock Purchase Plan (“ESPP”) for three and nine months ended September 30, 2013 and 2012 were as follows (in thousands):
		Three Months Ended						Nine Months Ended
		September 30,			September 30,			September 30,		September 30,
		2013			2012			2013		2012
	Stock options	$	737		$	1,490		$	2,922	$	3994
	Restricted stock units		453			341			1,287		865
	Performance stock units (“MSUs”)		276			229			776		353
	ESPP		235			150			807		392
	Total share-based compensation	$	1,701		$	2,210		$	5,792	$	5,604
	Income tax benefit	$	524		$	711		$	1,738	$	1,805
Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights Granted Under our Employee Stock Purchase Plan	'
	The assumptions used to estimate the fair value of stock options granted and stock purchase rights granted under our Employee Stock Purchase Plan (the “Purchase Plan”) for the nine months ended September 30, 2013 and 2012 are as follows:
		Options			ESPP
		Nine Months Ended			Nine Months Ended
		September 30,		September 30,	September 30,		September 30,
		2013		2012	2013		2012
	Volatility	50.03 – 53.58%		53.67 – 54.17%	28.63 – 41.52%		42.12 – 44.17%
	Expected term (years)	5.61 – 5.67		5.60 – 5.63	1.25		1.25
	Risk free interest rate	0.77 – 1.40%		0.63 – 1.01%	0.08 – 0.35%		0.13 – 0.17%
	Expected dividend yield	0%		0%	0%		0%
	Forfeiture rate	2 – 3%		2 – 4%	N/A		N/A
Schedule of Weighted-Average Common Shares Used to Calculate Basic Net Income Per Share	'
	The table below reconciles the weighted-average common shares used to calculate basic net income per share with the weighted-average common shares used to calculate diluted net income per share (in thousands).
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013		2012
	Weighted-average common shares outstanding		48,175			49,207			48,046		49,156
	Weighted-average dilutive common equivalent shares under the treasury stock method		3,253			3,587			2,805		3,638
	Weighted-average common shares used in computing diluted net income per share		51,428			52,794			50,851		52,794

Acquisitions_Tables

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2013
Purchase Price Allocation Related to Acquired Assets and Useful Life	'
	The table below represents the allocation of the purchase price to the acquired net assets of Quiterian based on their estimated fair values as of October 16, 2012 and the associated estimated useful life at that date. Also, as with acquisitions that the Company has undertaken in the past, the Company initiated structural changes in its corporate structure in order to incorporate Quiterian. These changes in Company’s organizational structure are ongoing and could affect future estimates and assumptions.
		Amount			Useful life
		(in thousands)			(in years)
	Net tangible assets and liabilities	$	(2,061	)		N/A
	Existing technology		1,682			7
	Customer contracts and relationships		324			7
	Goodwill		5,255			N/A
	Total purchase price allocation	$	5,200

Fair_Value_Measurements_of_Fin1

Fair Value Measurements of Financial Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2013
Assets Measured at Fair Value on Recurring Basis	'
	The following table represents information about the Company’s investments measured at fair value (in thousands).
			Fair value of investments as of September 30, 2013
			Total		Quoted Prices		Significant			Significant
					In Active		Other			Unobservable
					Markets for		Observable			Inputs
					Identical		Inputs			(Level 3)
					Assets		(Level 2)
					(Level 1)
	Money market funds (1)		$	6,984	$	6,984	$	—		$	—
	Term deposits (1)			7,034		7,034		—			—
	Commercial paper (2)(3)			6,998		—		6,998			—
	Corporate bonds (2)			25,748		—		25,748			—
			$	46,764	$	14,018	$	32,746		$	—
			Fair value of investments as of December 31, 2012
			Total		Quoted Prices		Significant			Significant
					In Active		Other			Unobservable
					Markets for		Observable			Inputs
					Identical		Inputs			(Level 3)
					Assets		(Level 2)
					(Level 1)
	Money market funds (1)		$	5,595	$	5,595	$	—		$	—
	Term deposits (1)			8,000		8,000		—			—
	Commercial paper (2)			1,599		—		1,599			—
	Corporate bonds (2)			25,368		—		25,368			—
	Federal and municipal obligations (2)			2,000		—		2,000			—
			$	42,562	$	13,595	$	28,967		$	—
	-1	Included in cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheet.
	-2	Included in short-term investments in the Company’s Condensed Consolidated Balances Sheet.
	-3	Of this amount, approximately $1 million was included in cash equivalents at September 30, 2013.
Summary of Cash, Cash Equivalents and Short-Term Investments	'
	The Company’s cash, cash equivalents, and short-term investments are as follows (in thousands):
			Cost		Gross		Gross			Estimated
					Unrealized		Unrealized			Fair Value
					Gains		(Losses)
	Balance at September 30, 2013
	Classified as cash and cash equivalents:
	Cash		$	25,184	$	—	$	—		$	25,184
	Term deposits			7,034		—		—			7,034
	Money market funds			6,984		—		—			6,984
	Commercial paper			1,000		—		—			1,000
				40,202		—		—			40,202
	Classified as short-term investments:
	Commercial paper (4)			5,999		—		(1	)		5,998
	Corporate bonds (4)			25,752		—		(4	)		25,748
				31,751		—		(5	)		31,746
	Total		$	71,953	$	—	$	(5	)	$	71,948
	-4	Securities totaling approximately $20.8 million were in an unrealized loss position at September 30, 2013. None of these securities were in a continuous unrealized loss position since December 31, 2012 or were in continuous loss position for greater than 12 months.
			Cost		Gross		Gross			Estimated
					Unrealized		Unrealized			Fair Value
					Gains		(Losses)
	Balance at December 31, 2012
	Classified as cash and cash equivalents:
	Cash		$	23,888	$	—	$	—		$	23,888
	Term deposits			8,000		—		—			8,000
	Money market funds			5,595		—		—			5,595
				37,483		—		—			37,483
	Classified as short-term investments:
	Commercial paper (5)			1,599		—		—			1,599
	Corporate bonds (5)			25,350		28		(10	)		25,368
	Federal and municipal obligations (5)			2,000		—		—			2,000
				28,949		28		(10	)		28,967
	Total		$	66,432	$	28	$	(10	)	$	66,450
	-5	Securities totaling approximately $11.4 million were in an unrealized loss position at December 31, 2012. None of these securities were in a continuous unrealized loss position for greater than 12 months.

Restructuring_Charges_Tables

Restructuring Charges (Tables)	9 Months Ended
	Sep. 30, 2013
Restructuring Accrual Activity	'
	The following table summarizes the restructuring accrual activity during the nine months ended September 30, 2013 (in thousands):
			Severance			Facility			Total
			& Benefits			Related
	Balance at December 31, 2012		$	424		$	85		$	509
	Restructuring charges (Q1)			62			6			68
	Restructuring charges (Q2)			373			150			523
	Restructuring charges (Q3)			19			227			246
	Cash payments, net of rents collected on sublease			(850	)		(258	)		(1,108	)
	Adjustments (1)			2			(6	)		(4	)
	Balance at September 30, 2013:			30			204			234
	Less: Current portion:			(30	)		(127	)		(157	)
	Long-term balance at September 30, 2013 (2)		$	—		$	77		$	77
	-1	Adjustments mainly reflect the impact of foreign currency translation.
	-2	Included in “Other liabilities—long-term” section of the Condensed Consolidated Balance Sheet.

Segment_and_Geographic_Informa1

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2013
Revenues by Geographic Area	'
	Our revenues by geographic area were as follows (in thousands):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Revenues:
	North America	$	25,679	$	25,064	$	80,231	$	77,211
	Europe, Middle East, and Africa (EMEA)		5,082		4,799		17,675		18,817
	Asia Pacific and others		1,530		2,316		4,205		7,215
		$	32,291	$	32,179	$	102,111	$	103,243

Goodwill_and_Other_Purchased_I1

Goodwill and Other Purchased Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2013
Other Purchased Intangible Assets	'
	Other purchased intangible assets consist of the following (in thousands):
		September 30, 2013									December 31, 2012
		Gross			Accumulated			Net			Gross		Accumulated			Net
		Carrying			Amortization			Carrying			Carrying		Amortization			Carrying
		Amount						Amount			Amount					Amount
	Customer lists	$	22,350		$	(18,240	)	$	4,110		$	22,360	$	(17,394	)	$	4,966
	Purchased technologies		17,325			(12,194	)		5,131			17,377		(11,202	)		6,175
	Leases		47			(33	)		14			47		(25	)		22
	Foreign currency exchange		(33	)		—			(33	)		—		—			—
		$	39,689		$	(30,467	)	$	9,222		$	39,784	$	(28,621	)	$	11,163
Amortization Expense	'
	The expected remaining annual amortization expense is summarized as follows (in thousands):
	Fiscal Year	Purchased
		Technology and
		Intangibles
	2013 (remainder of year)	$	634
	2014		2,536
	2015		2,530
	2016		2,527
	2017 and thereafter		995
		$	9,222

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2013
Costs Related to Credit Facility	'
	The following table represents costs related to the Company’s credit facility (in thousands):
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
			2013			2012			2013			2012
	Amortization of debt issuance costs		$	3			17		$	43			51
	Unused line fees			—			38			75			114
			$	3		$	55		$	118		$	165
Summary of Authorized but Unissued shares	'
	Total authorized but unissued shares were 22,775,022 as of September 30, 2013.
	Plan Summary		Available for			Options and			Total Authorized But
			Grant			Awards			Unissued
						Outstanding (2)
	Amended and Restated 1998 Equity Incentive Plan			10,392,728			11,093,886			21,486,614
	2001 Supplemental Stock Plan			705,541			35,156			740,697
	1998 Non-Employee Director Option Plan			495,000			105,000			600,000
	Total Stock Plans			11,593,269			11,234,042			22,827,311
	Miscellaneous Stock Grants (1)			(52,289	)		—			(52,289	)
	Total Stock Plans Balance at September 30, 2013			11,540,980			11,234,042			22,775,022
	-1	Board approved 50,000 shares stock grant on February 17, 2011 to the beneficiary of a deceased senior executive in recognition of services performed. Also included are 2,289 shares of stock granted to an employee on April 22, 2013.
	-2	Total balance outstanding at September 30, 2013 includes 9,870,230 of options and 1,363,812 of RSU’s.
Summary of Stock Options Outstanding and Exercisable	'
	All vested stock options are exercisable. The following table summarizes information about stock options outstanding and exercisable as of September 30, 2013:
			Options Outstanding									Options Exercisable
	Range of Exercise Prices		Number of			Weighted-			Weighted-			Number of		Weighted-
			Shares			Average			Average			Shares		Average
						Remaining			Exercise					Exercise
						Contractual			Price					Price
						Life
	$1.86-$3.56			1,219,447			3.81 years		$	3.24			1,219,447	$	3.24
	$3.59-$4.44			1,209,258			2.05 years		$	3.83			1,195,021	$	3.83
	$4.45-$4.80			937,829			6.17 years		$	4.78			841,479	$	4.78
	$4.84-$5.31			1,227,070			4.20 years		$	5.15			1,122,672	$	5.14
	$5.32-$5.48			1,084,705			7.30 years		$	5.48			701,714	$	5.48
	$5.49-$6.00			1,122,529			8.98 years		$	5.57			63,622	$	5.68
	$6.02-$6.29			1,423,253			5.21 years		$	6.13			1,171,473	$	6.12
	$6.30-$8.39			1,646,139			7.80 years		$	6.47			719,100	$	6.52
	$1.86-$8.39			9,870,230			5.71 years		$	5.16			7,034,528	$	4.89
Summary of Stock Options Outstanding (Vested and Expected to Vest) and Exercisable	'
			September 30,			September 30,
			2013			2012
	Options Outstanding—Vested and Expected to Vest (net of expected forfeitures)
	Vested and expected to vest			9,767,803			11,919,426
	Aggregate intrinsic value (in thousands)		$	21,474		$	27,111
	Weighted average exercise price per share		$	5.15		$	4.76
	Weighted average remaining contractual term (in years)			5.67			5.55
	Options Exercisable
	Options currently exercisable			7,034,528			8,439,892
	Aggregate intrinsic value of currently exercisable options (in thousands)		$	17,346		$	22,674
	Weighted average exercise price per share		$	4.89		$	4.35
	Weighted average remaining contractual term (in years)			4.59			4.38
Summary of Restricted Stock Units	'
	Restricted stock unit activity for the nine months ended September 30, 2013 and 2012:
			September 30,			September 30,
			2013			2012
	Beginning outstanding balance			577,374			384,687
	Awarded			447,500			205,000
	Released			(21,062	)		(12,313	)
	Ending outstanding balance			1,003,812			577,374
Weighted Average Grant Date Fair Value of Restricted Stock Units Granted	'
	The weighted average grant date fair value of restricted stock units granted during the nine months ended September 30, 2013 and 2012 were $5.73 and $6.40 per unit, respectively.
			Number of			Weighted Average			Aggregate
			Units			Remaining			Intrinsic Value
						Contractual Life			(thousands) (3)
						(years)
	Restricted stock units outstanding			1,003,812			1.4		$	7,378
	Restricted stock units vested and expected to vest (1)			975,043			1.37		$	7,167
	Restricted stock units vested and deferred shares (2)			308,375			—		$	2,267
	-1	Net of expected forfeitures
	-2	Not outstanding, therefore no remaining contractual life.
	-3	Intrinsic value is calculated based on market value of the Company’s stock price at the date of reporting.
Summary of Market-Performance Based Restricted Stock Units	'
	MSU activity for the nine months ended September 30, 2013 and 2012:
			September 30,			September 30,
			2013			2012
	Beginning outstanding balance			235,000			—
	Awarded			125,000			235,000
	Ending outstanding balance			360,000			235,000
Summary of Market-Performance Based Restricted Stock Units	'
	The weighted average grant date fair value of MSUs granted during the nine months ended September 30, 2013 and 2012 were $5.60 and $8.01 per unit, respectively.
			Number of			Weighted Average			Aggregate
			Units			Remaining			Intrinsic Value
						Contractual Life			(thousands) (2)
						(years)
	MSUs outstanding			360,000			1.1		$	2,646
	MSUs vested and expected to vest (1)			348,238			1.08		$	2,560
	-1	Net of expected forfeitures.
	-2	Intrinsic value is calculated based on market value of the Company’s stock price at the date of reporting.

Deferred_Revenue_Tables

Deferred Revenue (Tables)	9 Months Ended
	Sep. 30, 2013
Deferred Revenue	'
	Deferred revenue consists of the following (in thousands):
		September 30,			December 31,
		2013			2012
	Maintenance and support	$	40,903		$	41,007
	Other		3,091			5,409
		$	43,994		$	46,416
	Less: current portion		(41,468	)		(43,438	)
	Long-term deferred revenue	$	2,526		$	2,978

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Feb. 28, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Apr. 30, 2013

Sep. 30, 2013

Apr. 30, 2013

Apr. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Person

Asia

Restricted Share Units

Restricted Share Units

Restricted Share Units

Restricted Share Units

Market Performance Based Restricted Stock Units

Market Performance Based Restricted Stock Units

Minimum

Maximum

Restricted stock units

Restricted stock units

Entity

Market Performance Based Restricted Stock Units

Market Performance Based Restricted Stock Units

Non-employee director option plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum number of developers uses BIRT

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

Minimum number of customers, partners and employees using BIRT

'

'

200

'

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation

'

$16,000

'

$150,000

'

'

'

'

'

'

'

'

'

'

'

Award vesting period

'

'

'

'

'

'

'

'

'

'

'2 years

'2 years

'3 years

'4 years

'

Restricted stock units initially granted percentage

'

'

'

'

'

'

'

'

'

200.00%

200.00%

'

'

'

'

Restricted stock units vesting percentage

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

Restricted stock units vesting percentage after one year service period

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

Expected dividend yield in the option valuation model

'

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

Share reserve ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

1

'

RSU issued and granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,446,250

Weighted-average number of shares excluded from the calculations of diluted net income

652,677

2,222,368

1,880,436

2,151,624

'

103,175

216,200

119,091

113,349

'

'

'

'

'

'

Weighted average exercise price of excluded stock options

$6.16

$6.41

$6.01

$6.34

'

'

'

'

'

'

'

'

'

'

'

Tax benefit realized upon settlement

'

'

'Greater than a 50

'

'

'

'

'

'

'

'

'

'

'

'

Period of significant increase decrease in unrecognized tax benefits

'

'

'12 months

'

'

'

'

'

'

'

'

'

'

'

'

Number of liquidated subsidiaries

'

'

'

'

1

'

'

'

'

'

'

'

'

'

'

ShareBased_Compensation_Expens

Share-Based Compensation Expense and Related Income Tax Benefit (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Schedule Of Employee Service Share Based Compensation Expense Allocation [Line Items]	'	'	'	'
Stock options	$737	$1,490	$2,922	$3,994
Restricted stock units	453	341	1,287	865
Performance stock units ("MSUs")	276	229	776	353
ESPP	235	150	807	392
Total share-based compensation	1,701	2,210	5,792	5,604
Income tax benefit	$524	$711	$1,738	$1,805

Assumptions_Used_to_Estimate_F

Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights Granted Under our Employee Stock Purchase Plan (Detail)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Options	'	'
Expected dividend yield	0.00%	0.00%
Options | Minimum	'	'
Volatility	50.03%	53.67%
Expected term (years)	'5 years 7 months 10 days	'5 years 7 months 6 days
Risk free interest rate	0.77%	0.63%
Forfeiture rate	2.00%	2.00%
Options | Maximum	'	'
Volatility	53.58%	54.17%
Expected term (years)	'5 years 8 months 1 day	'5 years 7 months 17 days
Risk free interest rate	1.40%	1.01%
Forfeiture rate	3.00%	4.00%
Employee Stock	'	'
Expected term (years)	'1 year 3 months	'1 year 3 months
Expected dividend yield	0.00%	0.00%
Employee Stock | Minimum	'	'
Volatility	28.63%	42.12%
Risk free interest rate	0.08%	0.13%
Employee Stock | Maximum	'	'
Volatility	41.52%	44.17%
Risk free interest rate	0.35%	0.17%

Schedule_of_WeightedAverage_Co

Schedule of Weighted-Average Common Shares Used to Calculate Basic Net Income per Share (Detail)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Reconciliation Of Basic Weighted Average Shares To Diluted Weighted Average Shares [Line Items]	'	'	'	'
Weighted-average shares of common stock outstanding	48,175	49,207	48,046	49,156
Weighted-average dilutive common equivalent shares under the treasury stock method	3,253	3,587	2,805	3,638
Weighted-average common shares used in computing diluted net income per share	51,428	52,794	50,851	52,794

Acquisitions_Additional_Inform

Acquisitions - Additional Information (Detail) (Quiterian S.L., USD $)	1 Months Ended
	Oct. 16, 2012
Quiterian S.L.	'
Business Acquisition [Line Items]	'
Business acquisition, Percentage of outstanding shares acquired	100.00%
Business acquisition, amount of consideration	$5,200,000
Percentage of holdback upon closing of acquisition	10.00%
Business acquisition, Potential additional compensation payments	3,000,000
Business acquisition, Potential additional compensation payments period	'3 years
Business acquisition, transaction costs	354,000
Business acquisition, cash	505,000
Business acquisition, trade receivables	519,000
Business acquisition, notes payable	$2,200,000

Purchase_Price_Allocation_Rela

Purchase Price Allocation Related to Acquired Assets and Useful Life (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Oct. 16, 2012	Oct. 16, 2012	Oct. 16, 2012
In Thousands, unless otherwise specified			Quiterian S.L.	Existing technology	Customer contracts and relationships
				Quiterian S.L.	Quiterian S.L.
Business Acquisition [Line Items]	'	'	'	'	'
Net tangible assets and liabilities	'	'	($2,061)	'	'
Purchase price allocated to intangible assets	'	'	'	1,682	324
Goodwill	51,865	51,821	5,255	'	'
Total purchase price allocation	'	'	$5,200	'	'
Weighted Average Useful life	'	'	'	'7 years	'7 years

Assets_Measured_at_Fair_Value_

Assets Measured at Fair Value on Recurring Basis (Detail) (USD $)	Sep. 30, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	$46,764		$42,562
Money market funds	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	6,984	[1]	5,595	[1]
Term deposits	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	7,034	[1]	8,000	[1]
Commercial paper	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	6,998	[2],[3]	1,599	[2]
Corporate bonds	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	25,748	[2]	25,368	[2]
Federal and municipal obligations	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	'		2,000	[2]
Quoted Prices In Active Markets for Identical Assets (Level 1)	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	14,018		13,595
Quoted Prices In Active Markets for Identical Assets (Level 1) | Money market funds	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	6,984	[1]	5,595	[1]
Quoted Prices In Active Markets for Identical Assets (Level 1) | Term deposits	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	7,034	[1]	8,000	[1]
Significant Other Observable Inputs (Level 2)	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	32,746		28,967
Significant Other Observable Inputs (Level 2) | Commercial paper	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	6,998	[2],[3]	1,599	[2]
Significant Other Observable Inputs (Level 2) | Corporate bonds	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	25,748	[2]	25,368	[2]
Significant Other Observable Inputs (Level 2) | Federal and municipal obligations	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Total, Estimated Fair Value	'		$2,000	[2]
[1]	Included in cash and cash equivalents in the Company's Condensed Consolidated Balance Sheet.
[2]	Included in short-term investments in the Company's Condensed Consolidated Balances Sheet.
[3]	Of this amount, approximately $1 million was included in cash equivalents at September 30, 2013.

Assets_Measured_at_Fair_Value_1

Assets Measured at Fair Value on Recurring Basis (Parenthetical) (Detail) (USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'
Cash and cash equivalents, Cost	$1

Summary_of_Cash_Cash_Equivalen

Summary of Cash, Cash Equivalents and Short-Term Investments (Detail) (USD $)	Sep. 30, 2013		Dec. 31, 2012		Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Gross Unrealized Gains	'		'		'	'
Short-term investment, Cost	'		28		'	'
Cash and Cash equivalent, Gross Unrealized Losses	'		'		'	'
Short-term investment, Gross Unrealized (Losses)	-5		'		'	'
Gross Unrealized Losses	-5		-10		'	'
Cash and cash equivalents, Cost	40,202		37,483		39,453	38,759
Gross Unrealized Gains	'		28		'	'
Short-term investment, Gross Unrealized (Losses)	-20,800		-10		'	'
Cash	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Gross Unrealized Gains	'		'		'	'
Cash and Cash equivalent, Gross Unrealized Losses	'		'		'	'
Term deposits	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Gross Unrealized Gains	'		'		'	'
Cash and Cash equivalent, Gross Unrealized Losses	'		'		'	'
Money market funds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Gross Unrealized Gains	'		'		'	'
Cash and Cash equivalent, Gross Unrealized Losses	'		'		'	'
Federal and municipal obligations	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Gross Unrealized (Losses)	'		-11,400		'	'
Corporate bonds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Cost	'		28	[1]	'	'
Short-term investment, Gross Unrealized (Losses)	-4	[2]	-10	[1]	'	'
Commercial paper	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Gross Unrealized Gains	'		'		'	'
Cash and Cash equivalent, Gross Unrealized Losses	'		'		'	'
Short-term investment, Gross Unrealized (Losses)	-1	[2]	'		'	'
Estimated Fair Value	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	40,202		37,483		'	'
Short-term investment, Cost	31,746		'		'	'
Total	71,948		66,450		'	'
Short-term investment, Cost	'		28,967		'	'
Estimated Fair Value | Cash	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	25,184		23,888		'	'
Estimated Fair Value | Term deposits	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	7,034		8,000		'	'
Estimated Fair Value | Money market funds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	6,984		5,595		'	'
Estimated Fair Value | Federal and municipal obligations	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Cost	'		2,000	[1]	'	'
Estimated Fair Value | Corporate bonds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Cost	25,748	[2]	25,368	[1]	'	'
Estimated Fair Value | Commercial paper	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	1,000		'		'	'
Short-term investment, Cost	5,998	[2]	1,599	[1]	'	'
Cost	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	40,202		'		'	'
Short-term investment, Cost	31,751		28,949		'	'
Total	71,953		66,432		'	'
Cash and cash equivalents, Cost	'		37,483		'	'
Cost | Cash	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	25,184		'		'	'
Cash and cash equivalents, Cost	'		23,888		'	'
Cost | Term deposits	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	7,034		'		'	'
Cash and cash equivalents, Cost	'		8,000		'	'
Cost | Money market funds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	6,984		'		'	'
Cash and cash equivalents, Cost	'		5,595		'	'
Cost | Federal and municipal obligations	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Cost	'		2,000	[1]	'	'
Cost | Corporate bonds	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Short-term investment, Cost	25,752	[2]	25,350	[1]	'	'
Cost | Commercial paper	'		'		'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'	'
Cash and cash equivalents, Cost	1,000		'		'	'
Short-term investment, Cost	$5,999	[2]	$1,599	[1]	'	'
[1]	Securities totaling approximately $11.4 million were in an unrealized loss position at December 31, 2012. None of these securities were in a continuous unrealized loss position for greater than 12 months.
[2]	Securities totaling approximately $20.8 million were in an unrealized loss position at September 30, 2013. None of these securities were in a continuous unrealized loss position since December 31, 2012 or were in continuous loss position for greater than 12 months.

Summary_of_Cash_Cash_Equivalen1

Summary of Cash, Cash Equivalents and Short-Term Investments (Parenthetical) (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Unrealized loss	$20,800	$10
Available for sale securities gross unrealized losses duration of loss	'Greater than 12 months	'Greater than 12 months
Federal and municipal obligations	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Unrealized loss	'	$11,400

Fair_Value_Measurements_of_Fin2

Fair Value Measurements of Financial Assets and Liabilities - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013
Maturity period of short term investments	'Beyond 90 days
Stated maturity period of short term investments	'One year or more

Restructuring_Charges_Addition

Restructuring Charges - Additional Information (Detail) (USD $)	3 Months Ended				6 Months Ended	9 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
					Employee
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'
Number of positions eliminated	'	'	'	'	13	'	'
Restructuring charges	$246,000	$523,000	$68,000	$21,000	'	$837,000	$54,000
North American Product Development and Global Sales and Marketing Operations	'	'	'	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'
Restructuring charges	'	'	'	'	551,000	'	'
Toronto, Canada, Idle Facility	'	'	'	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'
Restructuring charges	145,000	'	'	'	136,000	'	'
French Operation	'	'	'	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'
Reversal of previously accrued severance liability	'	'	'	'	-178,000	'	'
Idle Xenos Group Inc. Facility, Europe	'	'	'	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'
Lease termination costs	($71,000)	'	'	'	'	'	'

Restructuring_Accrual_Activity

Restructuring Accrual Activity (Detail) (USD $)	3 Months Ended					9 Months Ended
	Sep. 30, 2013		Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013		Sep. 30, 2012	Dec. 31, 2012
Beginning balance	'		'	$509,000	'	$509,000		'	'
Restructuring charges	246,000		523,000	68,000	21,000	837,000		54,000	'
Cash payments, net of rents collected on sublease	'		'	'	'	-1,108,000		'	'
Adjustments	'		'	'	'	-4,000	[1]	'	'
Ending balance	234,000		'	'	'	234,000		'	'
Less: Current portion:	-157,000		'	'	'	-157,000		'	-509,000
Long-term balance at June 30, 2013	77,000	[2]	'	'	'	77,000	[2]	'	'
Severance And Related Benefits	'		'	'	'	'		'	'
Beginning balance	'		'	424,000	'	424,000		'	'
Restructuring charges	19,000		373,000	62,000	'	'		'	'
Cash payments, net of rents collected on sublease	'		'	'	'	-850,000		'	'
Adjustments	'		'	'	'	2,000	[1]	'	'
Ending balance	30,000		'	'	'	30,000		'	'
Less: Current portion:	-30,000		'	'	'	-30,000		'	'
Facility Related	'		'	'	'	'		'	'
Beginning balance	'		'	85,000	'	85,000		'	'
Restructuring charges	227,000		150,000	6,000	'	'		'	'
Cash payments, net of rents collected on sublease	'		'	'	'	-258,000		'	'
Adjustments	'		'	'	'	-6,000	[1]	'	'
Ending balance	204,000		'	'	'	204,000		'	'
Less: Current portion:	-127,000		'	'	'	-127,000		'	'
Long-term balance at June 30, 2013	$77,000	[2]	'	'	'	$77,000	[2]	'	'
[1]	Adjustments mainly reflect the impact of foreign currency translation.
[2]	Included in "Other liabilities-long-term" section of the Condensed Consolidated Balance Sheet.

Revenues_by_Geographic_Area_De

Revenues by Geographic Area (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Operating Statistics [Line Items]	'	'	'	'
Revenues	$32,291	$32,179	$102,111	$103,243
North America	'	'	'	'
Operating Statistics [Line Items]	'	'	'	'
Revenues	25,679	25,064	80,231	77,211
Europe, Middle East, and Africa	'	'	'	'
Operating Statistics [Line Items]	'	'	'	'
Revenues	5,082	4,799	17,675	18,817
Asia Pacific and others	'	'	'	'
Operating Statistics [Line Items]	'	'	'	'
Revenues	$1,530	$2,316	$4,205	$7,215

Segment_and_Geographic_Informa2

Segment and Geographic Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013
	Segment
Segment Reporting Information [Line Items]	'
Number of operating segments	1

Goodwill_and_Other_Purchased_I2

Goodwill and Other Purchased Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'
Goodwill	$51,865,000	'	$51,865,000	'	$51,821,000
Amortization of intangible assets	301,000	289,000	865,000	867,000	'
Additions to purchased intangible assets	'	'	'	'	2,000,000
Purchased technology and other intangibles	'	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortization of intangible assets	634,000	562,000	1,900,000	1,700,000	'
Purchased technologies	'	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortization of intangible assets	$333,000	$273,000	$1,000,000	$820,000	'
Estimated useful economic life	'	'	'7 years	'	'
Customer lists	'	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'
Estimated useful economic life	'	'	'7 years	'	'
Leases	'	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'
Estimated useful economic life	'	'	'5 years	'	'

Other_Purchased_Intangible_Ass

Other Purchased Intangible Assets (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$39,689	$39,784
Accumulated Amortization	-30,467	-28,621
Net Balance	9,222	11,163
Customer lists	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	22,350	22,360
Accumulated Amortization	-18,240	-17,394
Net Balance	4,110	4,966
Purchased technologies	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	17,325	17,377
Accumulated Amortization	-12,194	-11,202
Net Balance	5,131	6,175
Leases	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	47	47
Accumulated Amortization	-33	-25
Net Balance	14	22
Foreign currency exchange	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	-33	'
Net Balance	($33)	'

Amortization_Expense_Detail

Amortization Expense (Detail) (Purchased technology and other intangibles, USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Purchased technology and other intangibles	'
Finite-Lived Intangible Assets [Line Items]	'
2013 (remainder of year)	$634
2014	2,536
2015	2,530
2016	2,527
2017 and thereafter	995
Amortization expense	$9,222

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended			9 Months Ended
	Oct. 16, 2012	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Nov. 28, 2011
	Agreement				CreditFacility			sqft
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Write-off of unamortized costs related to old credit facility	'	'	$188,000	'	$188,000	'	'	'
Balance available under revolving credit facility	'	50,000,000	'	'	50,000,000	'	'	'
Balance owed under credit facility	'	0	'	'	0	'	'	'
Consolidated cash flow leverage ratio	'	'	'	'	2.5	'	'	'
Consolidated cash flow leverage ratio	'	'	'	'	1	'	'	'
Number of loan agreements	2	'	'	'	'	'	'	'
Frequency of loan repayment	'Quarterly	'	'	'	'	'	'	'
Loan repayment period, start	'2014-06	'	'	'	'	'	'	'
Loan repayment period, end	'2022-09	'	'	'	'	'	'	'
Notes payable	874,000	874,000	'	'	874,000	'	843,000	'
Additional office space	'	'	'	'	'	'	'	58,000
Sublease agreement term (in years)	'	'10 years	'	'	'10 years	'	'	'
Landlord incentives	'	'	'	'	'	'	'	2,600,000
Deferred rent	'	3,400,000	'	'	3,400,000	'	'	'
Deferred tax liability classified as short term debt	'	261,000	'	'	261,000	'	'	'
Deferred tax liability classified as long term debt	'	3,100,000	'	'	3,100,000	'	'	'
Lease expiration date	'	'	'	'	31-May-22	'	'	'
Letters of Credit	'	'	'	'	2	'	'	'
Letter of credit amount	'	225,300	'	'	225,300	'	88,000	'
Lease rent	'	1,100,000	'	1,200,000	3,300,000	3,100,000	'	'
Facility related charges	'	128,000	'	236,000	441,000	1,000,000	'	'
Minimum percentage of total combined voting power of outstanding securities required for RSU to vest in full	'	'	'	'	50.00%	'	'	'
Option vesting term	'	'	'	'	'10 years	'	'	'
Weighted average grant date fair value	'	'	'	'	$3.38	'	'	'
Total intrinsic value of options exercised	'	'	'	'	2,400,000	'	'	'
Number of shares reserved for future grants	'	11,540,980	'	'	11,540,980	'	'	'
Number of shares reserved for grants	'	2,800,301	'	'	2,800,301	'	'	'
Maximum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Fixed charged coverage ratio	'	'	'	'	1.75	'	'	'
Minimum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Fixed charged coverage ratio	'	'	'	'	1	'	'	'
Non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Percentage of options vesting	'	'	'	'	25.00%	'	'	'
New Revolving Credit Facility Agreement	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Secured revolving line of credit, principal amount	'	$50,000,000	'	'	$50,000,000	'	'	'
New Revolving Credit Facility Agreement | London Interbank Offered Rate (LIBOR) | Maximum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	2.00%	'	'	'
New Revolving Credit Facility Agreement | London Interbank Offered Rate (LIBOR) | Minimum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	1.50%	'	'	'
New Revolving Credit Facility Agreement | Prime Rate | Maximum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	1.00%	'	'	'
New Revolving Credit Facility Agreement | Prime Rate | Minimum	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	0.50%	'	'	'
New Revolving Credit Facility Agreement | Federal Funds Rate	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	0.50%	'	'	'
New Revolving Credit Facility Agreement | One Month Libor	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Interest rate	'	'	'	'	1.00%	'	'	'
Restricted stock units	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Award vesting period	'	'	'	'	'4 years	'	'	'
Weighted average grant date fair value of equity instruments other than option	'	'	'	'	$5.73	$6.40	'	'
Restricted stock units | Non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Option to purchase	'	'	'	'	12,500	'	'	'
Restricted stock units | Continuing non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Option to purchase	'	'	'	'	16,000	'	'	'
Options | Non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Number of shares underlying options issued	'	'	'	'	25,000	'	'	'
Award vesting period	'	'	'	'	'4 years	'	'	'
Market Performance Based Restricted Stock Units	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Weighted average grant date fair value of equity instruments other than option	'	'	'	'	$5.60	$8.01	'	'
Amended and Restated 1998 Equity Incentive Plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Percentage of options vesting	'	'	'	'	25.00%	'	'	'
Number of shares reserved for grants	'	10,392,728	'	'	10,392,728	'	'	'
Amended and Restated 1998 Equity Incentive Plan | Non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Percentage of options vesting	'	'	'	'	25.00%	'	'	'
Award vesting period	'	'	'	'	'3 years	'	'	'
Amended and Restated 1998 Equity Incentive Plan | Continuing non-employee director option plan	'	'	'	'	'	'	'	'
Commitments and Contingencies [Line Items]	'	'	'	'	'	'	'	'
Award vesting period	'	'	'	'	'13 months	'	'	'

Cost_Related_to_Credit_Facilit

Cost Related to Credit Facility (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Amortization of debt issuance costs	$3	$17	$43	$51
Unused line fees	'	38	75	114
Total	$3	$55	$118	$165

Schedule_of_Share_Based_Compen

Schedule of Share Based Compensation Shares as Result of Executive Option Under Various Plans (Detail)	Sep. 30, 2013
Commitments and Contingencies [Line Items]	'
Share Based Compensation Arrangement By Share Based Payment Award Options Balance Stock Plan Balance Available For Grant	11,540,980
Share Based Compensation Arrangement By Share Based Payment Award Options Balance Stock Plan Balance Outstanding	11,234,042	[1]
Share Based Compensation Arrangement By Share Based Payment Award Options Balance Stock Plan Authorized But Unissued	22,775,022
Available for Grant	2,800,301
Amended and Restated 1998 Equity Incentive Plan	'
Commitments and Contingencies [Line Items]	'
Available for Grant	10,392,728
Options and Awards Outstanding, Number of Shares	11,093,886	[1]
Total Authorized But Un-issued	21,486,614
2001 Supplemental Stock Plan	'
Commitments and Contingencies [Line Items]	'
Available for Grant	705,541
Options and Awards Outstanding, Number of Shares	35,156	[1]
Total Authorized But Un-issued	740,697
1998 Non-Employee Director Option Plan	'
Commitments and Contingencies [Line Items]	'
Available for Grant	495,000
Options and Awards Outstanding, Number of Shares	105,000	[1]
Total Authorized But Un-issued	600,000
Options	'
Commitments and Contingencies [Line Items]	'
Available for Grant	11,593,269
Options and Awards Outstanding, Number of Shares	11,234,042	[1]
Total Authorized But Un-issued	22,827,311
Miscellaneous Stock Grant	'
Commitments and Contingencies [Line Items]	'
Available for Grant	-52,289	[2]
Total Authorized But Un-issued	-52,289	[2]
[1]	Total balance outstanding at September 30, 2013 includes 9,870,230 of options and 1,363,812 of RSU's.
[2]	Board approved 50,000 shares stock grant on February 17, 2011 to the beneficiary of a deceased senior executive in recognition of services performed. Also included are 2,289 shares of stock granted to an employee on April 22, 2013.

Schedule_of_Share_Based_Compen1

Schedule of Share Based Compensation Shares as Result of Executive Option Under Various Plans (Parenthetical) (Detail)	1 Months Ended
	Apr. 22, 2013	Sep. 30, 2013	Feb. 17, 2011	Sep. 30, 2013
			Former Senior Executive Officer	RSUs granted inception to date
Commitments and Contingencies [Line Items]	'	'	'	'
Stock granted	'	11,540,980	50,000	'
Stock granted to employee	2,289	'	'	'
Options Outstanding	'	9,870,230	'	'
Options and Awards Outstanding, Number of Shares	'	'	'	1,363,812

Summary_of_Stock_Option_Outsta

Summary of Stock Option Outstanding and Exercisable (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013
Range One	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$1.86
Range of Exercise Prices, Upper Limit	$3.56
Options Outstanding, Number of Shares	1,219,447
Options Outstanding, Weighted Average Remaining Contractual Life	'3 years 9 months 22 days
Options Outstanding, Weighted Average Exercise Price	$3.24
Options Exercisable, Number of Shares	1,219,447
Options Exercisable, Weighted Average Exercise Price	$3.24
Range Two	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$3.59
Range of Exercise Prices, Upper Limit	$4.44
Options Outstanding, Number of Shares	1,209,258
Options Outstanding, Weighted Average Remaining Contractual Life	'2 years 18 days
Options Outstanding, Weighted Average Exercise Price	$3.83
Options Exercisable, Number of Shares	1,195,021
Options Exercisable, Weighted Average Exercise Price	$3.83
Range Three	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$4.45
Range of Exercise Prices, Upper Limit	$4.80
Options Outstanding, Number of Shares	937,829
Options Outstanding, Weighted Average Remaining Contractual Life	'6 years 2 months 1 day
Options Outstanding, Weighted Average Exercise Price	$4.78
Options Exercisable, Number of Shares	841,479
Options Exercisable, Weighted Average Exercise Price	$4.78
Range Four	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$4.84
Range of Exercise Prices, Upper Limit	$5.31
Options Outstanding, Number of Shares	1,227,070
Options Outstanding, Weighted Average Remaining Contractual Life	'4 years 2 months 12 days
Options Outstanding, Weighted Average Exercise Price	$5.15
Options Exercisable, Number of Shares	1,122,672
Options Exercisable, Weighted Average Exercise Price	$5.14
Range Five	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$5.32
Range of Exercise Prices, Upper Limit	$5.48
Options Outstanding, Number of Shares	1,084,705
Options Outstanding, Weighted Average Remaining Contractual Life	'7 years 3 months 18 days
Options Outstanding, Weighted Average Exercise Price	$5.48
Options Exercisable, Number of Shares	701,714
Options Exercisable, Weighted Average Exercise Price	$5.48
Range Six	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$5.49
Range of Exercise Prices, Upper Limit	$6
Options Outstanding, Number of Shares	1,122,529
Options Outstanding, Weighted Average Remaining Contractual Life	'8 years 11 months 23 days
Options Outstanding, Weighted Average Exercise Price	$5.57
Options Exercisable, Number of Shares	63,622
Options Exercisable, Weighted Average Exercise Price	$5.68
Range Seven	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$6.02
Range of Exercise Prices, Upper Limit	$6.29
Options Outstanding, Number of Shares	1,423,253
Options Outstanding, Weighted Average Remaining Contractual Life	'5 years 2 months 16 days
Options Outstanding, Weighted Average Exercise Price	$6.13
Options Exercisable, Number of Shares	1,171,473
Options Exercisable, Weighted Average Exercise Price	$6.12
Range Eight	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$6.30
Range of Exercise Prices, Upper Limit	$8.39
Options Outstanding, Number of Shares	1,646,139
Options Outstanding, Weighted Average Remaining Contractual Life	'7 years 9 months 18 days
Options Outstanding, Weighted Average Exercise Price	$6.47
Options Exercisable, Number of Shares	719,100
Options Exercisable, Weighted Average Exercise Price	$6.52
Range Nine	'
Commitments and Contingencies [Line Items]	'
Range of Exercise Prices, Lower Limit	$1.86
Range of Exercise Prices, Upper Limit	$8.39
Options Outstanding, Number of Shares	9,870,230
Options Outstanding, Weighted Average Remaining Contractual Life	'5 years 8 months 16 days
Options Outstanding, Weighted Average Exercise Price	$5.16
Options Exercisable, Number of Shares	7,034,528
Options Exercisable, Weighted Average Exercise Price	$4.89

Summary_of_Stock_Option_Outsta1

Summary of Stock Option Outstanding (Vested and Expected to Vest) (Detail) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Options Outstanding-Vested and Expected to Vest (net of expected forfeitures)	'	'
Vested and expected to vest	9,767,803	11,919,426
Aggregate intrinsic value (in thousands)	$21,474	$27,111
Weighted average exercise price per share	$5.15	$4.76
Weighted average remaining contractual term (in years)	'5 years 8 months 1 day	'5 years 6 months 18 days
Options Exercisable	'	'
Options currently exercisable	7,034,528	8,439,892
Aggregate intrinsic value of currently exercisable options (in thousands)	$17,346	$22,674
Weighted average exercise price per share	$4.89	$4.35
Weighted average remaining contractual term (in years)	'4 years 7 months 2 days	'4 years 4 months 17 days

Summary_of_Restricted_Stock_Un

Summary of Restricted Stock Unit Activity (Detail)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Commitments and Contingencies [Line Items]	'	'
Ending outstanding balance	1,003,812	'
Restricted stock units	'	'
Commitments and Contingencies [Line Items]	'	'
Beginning outstanding balance	577,374	384,687
Awarded	447,500	205,000
Released	-21,062	-12,313
Ending outstanding balance	1,003,812	577,374

Weighted_Average_Grant_Date_Fa

Weighted Average Grant Date Fair Value of Restricted Stock Units Granted (Detail) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013
Restricted stock units outstanding, Number of Units	1,003,812
Restricted stock units vested and expected to vest, Number of Units	975,043	[1]
Restricted stock units vested and deferred shares, Number of Units	308,375	[2]
Restricted stock units outstanding, Weighted Average Remaining Contractual Life	'1 year 4 months 24 days
Restricted stock units vested and expected to vest, Weighted Average Remaining Contractual Life	'1 year 4 months 13 days	[1]
Restricted stock units vested and deferred shares, Weighted Average Remaining Contractual Life	'0 years	[2]
Restricted stock units outstanding, Aggregate Intrinsic Value	$7,378	[3]
Restricted stock units vested and expected to vest, Aggregate Intrinsic Value	7,167	[1],[3]
Restricted stock units vested and deferred shares, Aggregate Intrinsic Value	$2,267	[2],[3]
[1]	Net of expected forfeitures
[2]	Not outstanding, therefore no remaining contractual life.
[3]	Intrinsic value is calculated based on market value of the Company's stock price at the date of reporting.

MarketPerformance_Based_Restri

Market-Performance Based Restricted Stock Units (Detail)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Commitments and Contingencies [Line Items]	'	'
Ending outstanding balance	1,003,812	'
Market Performance Based Restricted Stock Units	'	'
Commitments and Contingencies [Line Items]	'	'
Beginning outstanding balance	235,000	'
Awarded	125,000	235,000
Ending outstanding balance	360,000	235,000

Summary_of_MarketPerformance_B

Summary of Market-Performance Based Restricted Stock Units (Detail) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013		Dec. 31, 2012	Sep. 30, 2012
MSUs outstanding	1,003,812		'	'
Market performance based restricted stock units outstanding, Weighted-Average Remaining Contractual Life (Years)	'1 year 4 months 24 days		'	'
MSUs outstanding	$7,378	[1]	'	'
MSUs vested and expected to vest	7,167	[1],[2]	'	'
Market Performance Based Restricted Stock Units	'		'	'
MSUs outstanding	360,000		235,000	235,000
MSUs vested and expected to vest	348,238	[3]	'	'
Market performance based restricted stock units outstanding, Weighted-Average Remaining Contractual Life (Years)	'1 year 1 month 6 days		'	'
Market performance based restricted stock units vested and expected to vest, Weighted-Average Remaining Contractual Life (Years)	'1 year 29 days	[3]	'	'
MSUs outstanding	2,646	[1]	'	'
MSUs vested and expected to vest	$2,560	[1],[3]	'	'
[1]	Intrinsic value is calculated based on market value of the Company's stock price at the date of reporting.
[2]	Net of expected forfeitures
[3]	Net of expected forfeitures.

Deferred_Revenue_Detail

Deferred Revenue (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue	$43,994	$46,416
Less: current portion	-41,468	-43,438
Long-term deferred revenue	2,526	2,978
Maintenance and support	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue	40,903	41,007
Other	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue	$3,091	$5,409

Deferred_Revenue_Additional_In

Deferred Revenue - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013
Period of maintenance and support	'12 months

Subsequent_Event_Additional_In

Subsequent Event - Additional Information (Detail) (2013 Share Repurchase Program, USD $)	1 Months Ended
In Millions, except Share data, unless otherwise specified	Jul. 29, 2013	Nov. 06, 2013
		Subsequent Event
Subsequent Event [Line Items]	'	'
Share Repurchase Program, Approved Amount	$40	'
Number of shares repurchased	'	547,899
Amount of shares repurchased under stock repurchase plan	'	$4.20